Non-follicular lymphoma

C3_NONFOLLICULAR_LYMPHOMA

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — C83 Hospital discharge: ICD-9 — 200 Hospital discharge: excluded ICD-9 — 200A Cause of death: ICD-10 — C83 Cause of death: ICD-9 — 200 Cause of death: excluded ICD-9 — 200A 2 out of 7 registries used, show all original rules.	4428
4. Check minimum number of events None	4428
5. Include endpoints None	4428
6. Filter based on genotype QC (FinnGen only)	3853

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF4
Parent code in ICD-10: C81-C96
Name in latin: Lymphoma non-Hodgkin diffusum

NAME	C3_NONFOLLICULAR_LYMPHOMA
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	C83
HD_ICD_9	200
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL	200A
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	C83
COD_ICD_9	200
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL	200A
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Non-follicular lymphoma based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	3853	1608	2245
Unadjusted period prevalence (%)	0.84	0.57	1.03
Median age at first event (years)	67.09	65.59	68.17

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
3981: Matched controls
39810

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

R59.9

ICD-10 Finland

Enlarged lymph nodes, unspecified

22.1

322.8

241

116

R50.9

ICD-10 Finland

Fever, unspecified

4.0

312.0

1184

3853

C82.9

ICD-10 Finland

Follicular lymphoma, unspecified

66.1

311.7

171

JN4JR

NOMESCO Finland

Whole body extensive metabolic PET with CT

21.3

310.2

235

117

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

63.9

307.7

418

R59.1

ICD-10 Finland

Generalized enlarged lymph nodes

28.2

307.7

434

172

C83.3

ICD-10 Finland

Diffuse large B-cell lymphoma

+∞

307.7

716

A03FA01

ATC

metoclopramide; systemic, rectal

7.6

307.7

2222

5704

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

14.0

307.7

380

297

D70.82

ICD-10 Finland

Drug-induced neutropenia

24.0

307.7

463

217

C82.1

ICD-10 Finland

Follicular lymphoma grade II

46.3

307.7

272

1XC02, ,

NOMESCO Finland

71.7

307.7

383

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

22.0

307.7

1319

877

C85.1

ICD-10 Finland

B-cell lymphoma, unspecified

155.5

307.7

380

C83.1

ICD-10 Finland

Mantle cell lymphoma

+∞

307.7

533

ZX120

NOMESCO Finland

Intravenous

5.0

307.7

913

2249

M04AA01

ATC

allopurinol; systemic

8.5

307.7

1964

4110

C83.9

ICD-10 Finland

Non-follicular (diffuse) lymphoma, unspecified

4693.3

307.7

431

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

161.0

307.7

3000

742

L03AA13

ATC

pegfilgrastim; parenteral

24.3

307.7

1225

716

JN4AD

NOMESCO Finland

Body CT examination

5.5

307.7

1304

3259

XW000

NOMESCO Finland

Bone marrow biopsy

23.1

307.7

1327

844

JN4BD

NOMESCO Finland

Extensive body CT

8.2

307.7

1493

2703

L03AA02

ATC

filgrastim; parenteral

41.3

307.7

1282

453

WW300

NOMESCO Finland

Transfer of autologic stem cells

58.2

307.7

215

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

9.3

307.7

833

1099

C83.00

ICD-10 Finland

Lymphocytic lymphoma

+∞

307.7

386

A04AA02

ATC

granisetron; systemic, transdermal

6.9

307.7

799

1401

JN6AD

NOMESCO Finland

CT of torso and neck

35.4

307.7

759

263

A49.9

ICD-10 Finland

Bacterial infection, unspecified

4.4

307.7

1120

3273

C85.9

ICD-10 Finland

Non-Hodgkin lymphoma, unspecified

156.8

307.7

554

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

+∞

307.7

2263

PJD41

NOMESCO Finland

Excision of cervical lymph nodes

40.6

307.7

536

152

H02AB06

ATC

prednisolone; systemic

4.1

307.7

2821

14829

PJA10

NOMESCO Finland

Exploration of lymph nodes

30.1

307.7

433

161

C83.39

ICD-10 Finland

Diffuse non-Hodgkin's large cell lymphoma UNS

+∞

307.7

330

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

6.4

307.7

675

1237

Z51.1

ICD-10 Finland

Chemotherapy session for neoplasm

29.2

307.7

468

181

WW500

NOMESCO Finland

Blood transfusion

13.7

307.7

871

799

L03AA14

ATC

lipegfilgrastim; parenteral

15.5

307.7

362

255

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

9.8

307.7

696

841

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

52.5

307.7

773

182

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

51.8

307.7

1188

324

A04AA01

ATC

ondansetron; systemic, rectal

8.4

307.7

1139

1807

JN6BD

NOMESCO Finland

Extensive CT of torso and neck

39.6

307.7

301

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

20.1

307.7

737

446

9680/3-C77.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of lymph node, NOS

5568.6

307.7

500

C83.80

ICD-10 Finland

B-cell lymphoma in marginal zone

+∞

307.7

471

PJ2AT

NOMESCO Finland

Biopsy of lymphnode with ultrasound guidance

21.9

299.7

224

108

PJD45

NOMESCO Finland

Excision of inguinal lymph nodes

34.6

291.5

185

9680/3-C77.8

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of lymph nodes of multiple regions

2868.3

291.0

278

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

12.5

290.6

293

251

XZZ00

NOMESCO Finland

Active surveillance of a diagnosed cancer

11.6

281.5

298

275

TNE25

NOMESCO Finland

Drill biopsy of bone marrow, pelvis

16.0

271.0

235

155

C82.2

ICD-10 Finland

Follicular lymphoma grade III, unspecified

65.9

255.1

140

D69.6

ICD-10 Finland

Thrombocytopenia, unspecified

9.6

238.3

289

322

EN1BD

NOMESCO Finland

Very extensive CT examination of mouth and soft tissues of neck

11.4

232.1

247

229

H02AB02

ATC

dexamethasone; systemic

3.7

231.5

886

2844

C82.01

ICD-10 Finland

Follicular nodular lymphoma, grade I

56.0

230.0

130

212

Kela drug reimbursment

Gout

7.8

220.1

316

433

J05AB11

ATC

valaciclovir; oral

3.4

214.2

958

3385

ZX112

NOMESCO Finland

Subcutaneous

8.2

213.2

294

384

C91.1

ICD-10 Finland

Chronic lymphocytic leukaemia of B-cell type

12.5

212.3

212

178

Z94.8

ICD-10 Finland

Other transplanted organ and tissue status

33.0

208.5

134

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

3.3

203.4

959

3490

WZC00

NOMESCO Finland

Treatment plan or consultation

2.7

200.2

1968

10618

WW409

NOMESCO Finland

Other aferesis

52.8

197.7

113

Z85.7

ICD-10 Finland

Personal history of other malignant neoplasms of lymphoid, haematopoietic and related tissues

404.8

194.7

194

TPX10

NOMESCO Finland

Implantation of vascular injection port

6.5

193.8

334

556

WF003

NOMESCO Finland

Adjuvant radiotherapy

6.1

191.7

354

631

C82.00

ICD-10 Finland

Follicular nodular non-Hodgkin's lymphoma, ungraded

46.7

185.7

109

N02AA05

ATC

oxycodone; systemic

2.8

182.4

1294

5870

H02AB07

ATC

prednisone; oral

3.1

179.7

905

3401

C81.9

ICD-10 Finland

Hodgkin lymphoma, unspecified

39.0

179.5

110

EP1AE

NOMESCO Finland

Neck ultrasound examination

4.4

178.9

489

1221

R22.1

ICD-10 Finland

Localized swelling, mass and lump, neck

5.4

178.7

375

752

D70.89

ICD-10 Finland

Neutropenic splenomegaly

11.1

174.4

188

177

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

4.0

174.1

544

1500

L01AA02

ATC

chlorambucil; oral

28.9

171.7

115

L01CB01

ATC

etoposide; systemic

16.7

161.7

136

ZX108

NOMESCO Finland

Inhalation

15.8

159.5

138

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

5.9

157.1

296

536

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.4

152.5

2530

16639

JN5JR

NOMESCO Finland

Extensive PET-CT of upper body metabolism (eyebrows to thighs)

30.1

151.5

100

TGC00

NOMESCO Finland

Bronchial lavation

6.0

147.9

272

481

NEA10

NOMESCO Finland

Exploration of soft tissue of pelvis, percutaneous

18.8

144.8

115

390

Kela drug reimbursment

Ibrutinib

47.1

141.7

C81.1

ICD-10 Finland

Nodular sclerosis classical Hodgkin lymphoma

30.4

139.7

J17.3*B59

ICD-10 Finland

Pneumonia due to Pneumocystis carinii

20.7

138.2

105

PJ2AE

NOMESCO Finland

Lymphnode ultrasound examination

11.6

137.7

143

127

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

8.7

137.6

178

214

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

5.5

137.3

279

541

A02BC02

ATC

pantoprazole; systemic

2.6

136.3

3115

23059

2008X

ICD-9 Finland

Lymphosarcoma and reticulosarcoma, Other named variants

+∞

133.1

127

JN6DR

NOMESCO Finland

PET-CT of whole body metabolism

11.0

132.9

143

134

WF049

NOMESCO Finland

Radiotherapy of metastasis

4.5

131.9

344

823

WF004

NOMESCO Finland

Palliative radiotherapy

5.8

130.7

246

444

J01MA12

ATC

levofloxacin; systemic

2.5

128.9

1106

5366

YNB10

NOMESCO Finland

Collection of stem cells for transplant

42.4

125.0

C96.9

ICD-10 Finland

Malignant neoplasm of lymphoid, haematopoietic and related tissue, unspecified

69.2

124.6

XX3DW

NOMESCO Finland

Time consuming IT work

2.8

123.6

716

2858

AAG00

NOMESCO Finland

Stereotactic intracranial biopsy

35.7

122.7

1512

Kela drug reimbursment

Ibrutinib

43.7

122.5

Z51.5

ICD-10 Finland

Palliative care

2.9

122.4

678

2641

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

8.1

120.8

164

209

C83.89

ICD-10 Finland

Other types of diffuse non-Hodgkin's lymphoma

+∞

120.4

115

WF002

NOMESCO Finland

Radical radiotherapy

3.4

119.1

475

1527

9823/3-C42.1

ICD-O-3

B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow

11.6

117.7

122

108

9673/3-C42.1

ICD-O-3

Mantle cell lymphoma of bone marrow

+∞

115.2

110

PJD42

NOMESCO Finland

Excision of axillary lymph nodes

10.5

114.9

128

126

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

3.6

114.8

408

1217

B72

ICPC

Hodgkin Lymphoma

238.9

113.4

116

D69.5

ICD-10 Finland

Secondary thrombocytopenia

21.2

113.0

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

3.1

111.1

508

1771

WW402

NOMESCO Finland

Leucoferesis

61.9

109.7

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

4.2

109.1

307

776

XX9CD

NOMESCO Finland

Very extensive complementary CT

284.0

108.5

110

L01EL01

ATC

ibrutinib; oral

59.9

105.5

A41.9

ICD-10 Finland

Sepsis, unspecified

4.0

104.0

313

831

XW4XT

NOMESCO Finland

Biopsy of other inner organ with radiological guidance guidance

29.2

103.5

TAB00

NOMESCO Finland

Lumbar puncture

4.1

101.6

296

767

TPX15

NOMESCO Finland

Removal of vascular injection port

15.3

99.2

C83.33

ICD-10 Finland

Primary medical lymphoma with large B cells

+∞

98.3

9680/3-C71.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of brain, NOS

+∞

98.3

D47.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue, unspecified

23.3

98.2

YA1AD

NOMESCO Finland

CT examination of head and neck for dose design of radiotherapy

8.1

95.1

129

164

YJ1BD

NOMESCO Finland

Extensive CT examination of abdomen for dose design of radiotherapy

41.3

94.3

XW4AT

NOMESCO Finland

Biopsy of other inner organ with ultrasound guidance

16.7

91.8

EN1AD

NOMESCO Finland

CT examination of mouth and soft tissues of neck

7.4

89.0

131

183

D80.1

ICD-10 Finland

Nonfamilial hypogammaglobulinaemia

24.2

87.0

C83.01

ICD-10 Finland

Lymphoplasmacytic lymphoma

+∞

85.7

WZC30

NOMESCO Finland

Teaching

2.2

85.7

895

4619

C83.0

ICD-10 Finland

Small cell B-cell lymphoma

+∞

84.7

A07AA02

ATC

nystatin; oral

3.1

82.5

371

1273

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

4.1

80.2

230

588

YJ1AD

NOMESCO Finland

CT examination of abdomen for dose design of radiotherapy

16.1

79.6

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.9

79.6

1394

8654

2000B

ICD-9 Finland

Lymphosarcoma and reticulosarcoma, Reticulosarcoma[LYMPHOMA MALIGNUM DIFFUSUM]

+∞

79.4

9680/3-C42.1

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of bone marrow

+∞

79.4

JN4ED

NOMESCO Finland

Body CT examination with specail preparation

124.1

79.2

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

3.0

79.1

373

1315

WW200

NOMESCO Finland

Immunization

4.5

78.1

195

448

C83.34

ICD-10 Finland

Anaplastic large cell lymphoma

+∞

77.3

XW3AT

NOMESCO Finland

Biopsy of other superficial organ with ultrasound guidance

11.0

76.6

C85.7

ICD-10 Finland

Other specified types of non-Hodgkin lymphoma

201.4

76.5

B01AB10

ATC

tinzaparin; parenteral

2.4

76.4

603

2752

D38.3

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Mediastinum

14.0

75.0

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

3.0

74.3

344

1199

B01AB05

ATC

enoxaparin; parenteral

1.9

72.2

1474

9547

NK6CT

NOMESCO Finland

Bone biopsy with CT guidance

13.6

71.6

H02AB09

ATC

hydrocortisone; systemic

4.6

71.2

175

397

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

5.2

71.2

150

299

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.9

71.1

1236

7595

D64.9

ICD-10 Finland

Anaemia, unspecified

2.2

70.7

677

3348

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.0

70.6

954

5379

9680/3-C80.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of unknown primary site

700.5

70.3

J05AB01

ATC

aciclovir; systemic

2.0

70.2

970

5511

9673/3-C77.9

ICD-O-3

Mantle cell lymphoma of lymph node, NOS

+∞

70.0

UGC12

NOMESCO Finland

Flexible bronchoscopy

2.5

69.5

489

2113

9823/3-C77.9

ICD-O-3

B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of lymph node, NOS

87.3

69.2

C83.32

ICD-10 Finland

Centroblastic diffuse non-Hodgkin's lymphoma

+∞

68.9

2009X

ICD-9 Finland

Lymphosarcoma and reticulosarcoma[LYMPHOMA MALIGNUM (NON-HODGKIN) NUD]

+∞

67.9

C83.35

ICD-10 Finland

T-cell-rich B-cell lymphoma

+∞

67.9

9680/3-C09.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of tonsil, NOS

+∞

67.9

GD1AD

NOMESCO Finland

Thorax CT examination

2.7

66.7

405

1629

JN4CD

NOMESCO Finland

Very extensive body CT

3.3

65.8

257

808

TPH04

NOMESCO Finland

Cathetrisation of vein

1.9

65.7

1075

6447

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

3.9

65.7

198

524

JMA10

NOMESCO Finland

Transabdominal total splenectomy

10.2

65.6

TPJ00

NOMESCO Finland

Biopsy of superficial lymph node

20.2

65.3

ED1AA

NOMESCO Finland

Mandibular X-ray examination

9.7

64.9

R16.1

ICD-10 Finland

Splenomegaly, not elsewhere classified

24.5

64.8

9680/3-C16.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of stomach, NOS

+∞

64.8

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

2.2

64.4

611

3002

QX3AT

NOMESCO Finland

Ultrasound guided biopsy of subcutaneous tissue

8.3

63.7

103

D43.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Brain, supratentorial

10.2

62.9

9680/3-C77.0

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of lymph nodes of head, face and neck

+∞

61.6

FM1FN

NOMESCO Finland

Heart function isotope examination

11.4

61.3

WX408

NOMESCO Finland

General anesthesy, balanced

1.8

61.3

1151

7186

9591/3-C77.0

ICD-O-3

Malignant lymphoma, non-Hodgkin, NOS, of lymph nodes of head, face and neck

213.3

61.3

C83.71

ICD-10 Finland

Burkitt's tumour

+∞

59.5

C83.2

ICD-10 Finland

Mixed small and large cell (diffuse) non-Hodgkin's lymphoma

+∞

59.5

R06AE07

ATC

cetirizine; oral

1.7

58.2

1633

11423

C88.0

ICD-10 Finland

Waldenström macroglobulinaemia

16.5

58.2

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

2.2

57.8

522

2506

EMA10

NOMESCO Finland

Biopsy of tonsil

13.0

56.3

ZX070

NOMESCO Finland

Intensity modified radiotherapy

4.2

54.2

145

351

ZXF99

NOMESCO Finland

Other r3eason to interrupt procedure

9.3

53.1

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.4

52.5

410

1848

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.7

52.2

1325

8949

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

4.5

52.1

129

294

9591/3-C77.9

ICD-O-3

Malignant lymphoma, non-Hodgkin, NOS, of lymph node, NOS

96.4

51.9

J01MA14

ATC

moxifloxacin; systemic

2.2

51.6

458

2179

9673/3-C77.8

ICD-O-3

Mantle cell lymphoma of lymph nodes of multiple regions

+∞

51.1

YA1BD

NOMESCO Finland

Extensive CT examination of head and neck for dose design of radiotherapy

6.2

51.0

142

YNB00

NOMESCO Finland

Excision of bone marrow for transplantation

136.8

50.9

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.8

50.8

942

5807

B25.9

ICD-10 Finland

Cytomegaloviral disease, unspecified

15.5

49.4

JFB00

NOMESCO Finland

Partial resection of small intestine

4.4

49.4

124

286

9691/3-C77.9

ICD-O-3

Follicular lymphoma, grade 2 of lymph node, NOS

20.7

48.7

L04.0

ICD-10 Finland

Acute lymphadenitis of face, head and neck

7.0

47.0

105

9699/3-C77.9

ICD-O-3

Marginal zone B-cell lymphoma, NOS, of lymph node, NOS

+∞

47.0

B25.8

ICD-10 Finland

Other cytomegaloviral diseases

14.6

46.8

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

2.1

45.3

476

2414

1AA09, ,

NOMESCO Finland

65.8

45.2

C83.51

ICD-10 Finland

B-lymphoblastic lymphoma or leukemia

+∞

44.9

3AA13, ,

NOMESCO Finland

18.2

44.7

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.0

44.5

558

3018

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.1

44.2

469

2387

KFC00

NOMESCO Finland

Unilateral orchiectomy

7.4

44.1

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

4.1

44.0

123

308

E83.50

ICD-10 Finland

Hypercalcemia

4.7

43.9

102

221

C83

ICD-10 Finland

Non-follicular lymphoma

+∞

43.8

B00.2

ICD-10 Finland

Herpesviral gingivostomatitis and pharyngotonsillitis

12.0

43.7

AA1BD

NOMESCO Finland

Extensive CT of head and brain

3.4

42.6

155

465

C81.0

ICD-10 Finland

Nodular lymphocyte predominant Hodgkin lymphoma

16.8

41.9

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.9

41.8

567

3145

C83.8

ICD-10 Finland

Other non-follicular lymphoma

+∞

41.7

GEA20

NOMESCO Finland

Mediastinoscopy with excision of lesion

14.2

41.6

C03CA01

ATC

furosemide; systemic

1.6

41.1

1509

11031

9689/3-C42.2

ICD-O-3

Splenic marginal zone B-cell lymphoma of spleen

+∞

40.7

ZX131

NOMESCO Finland

Intrathecal

+∞

39.6

9680/3-C62.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of testis, NOS

+∞

39.6

D72.8

ICD-10 Finland

Other specified disorders of white blood cells

6.2

39.6

112

ZXE00

NOMESCO Finland

One hour or less

1.6

38.9

1489

10952

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.5

38.9

1926

15010

D48.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other specified sites

6.4

38.8

101

2000A

ICD-9 Finland

Lymphosarcoma and reticulosarcoma, Reticulosarcoma[LYMPHOMA MALIGNUM FOLLICULARE]

+∞

38.6

WX110

NOMESCO Finland

Infiltration anesthesia

1.6

38.4

2651

22212

I88.9

ICD-10 Finland

Nonspecific lymphadenitis, unspecified

9.3

38.3

D40.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Testis

7.4

38.1

9591/3-C77.2

ICD-O-3

Malignant lymphoma, non-Hodgkin, NOS, of intra-abdominal lymph nodes

381.1

38.1

AAA10

NOMESCO Finland

Biopsy through craniotomy

72.6

38.0

9699/3-C16.9

ICD-O-3

Marginal zone B-cell lymphoma, NOS, of stomach, NOS

+∞

37.6

KA1FN

NOMESCO Finland

Isotope renography

6.3

37.3

102

JN3AD

NOMESCO Finland

Abdominal CT examination

1.8

37.0

614

3624

GEA00

NOMESCO Finland

Mediastinoscopy

8.8

36.6

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

3.8

36.5

114

309

WD315

NOMESCO Finland

Multiple therapy of methastized malignancy with biomodifiers

10.1

36.3

B02.9

ICD-10 Finland

Zoster without complication

2.1

35.8

350

1721

D48.3

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Retroperitoneum

11.7

35.2

ZX090

NOMESCO Finland

Other technic of radiotherapy

3.0

34.7

155

527

9680/3-C77.2

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of intra-abdominal lymph nodes

+∞

34.4

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

3.0

34.2

158

547

PJ3AT

NOMESCO Finland

Cytology of lymphnode with ultrasound guidance

4.9

34.2

155

N05CF01

ATC

zopiclone; oral

1.5

34.1

1312

9592

127

Kela drug reimbursment

Transplant complication

4.2

34.1

216

D80.8

ICD-10 Finland

Other immunodeficiencies with predominantly antibody defects

65.6

34.0

D48.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Bone and articular cartilage

4.5

33.4

186

KF8AE

NOMESCO Finland

Ultrasound examination of scrotum

3.1

33.4

145

485

XGX32

NOMESCO Finland

Bronchoscopic ultrasonography

5.0

33.3

143

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.5

33.3

1409

10503

QX3HE

NOMESCO Finland

Ultrsound examination of lesion close to skin

3.8

33.2

101

269

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.5

32.9

1530

11626

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.5

32.6

206

839

L01XX52

ATC

venetoclax; oral

11.9

32.5

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.0

32.5

408

2195

C84.59

ICD-10 Finland

Other and unspecified T-cell lymphomas

37.7

32.4

C83.59

ICD-10 Finland

Lymphoblastic lymphoma of indeterminate type

+∞

32.3

TGD00

NOMESCO Finland

Needle biopsy of lung

6.7

31.8

V03AF03

ATC

calcium folinate; systemic

11.5

31.8

WX402

NOMESCO Finland

General anaesthesia

1.6

31.3

848

5694

L01XE27

ATC

[U] ibrutinib

39.4

31.2

J02AC03

ATC

voriconazole; systemic

11.1

31.1

C71.90

ICD-10 Finland

Malignant tumor in unspecified localization in the brain without histology

10.1

30.9

CA1CG

NOMESCO Finland

Eye and orbita extensive MRI examination with high intensity magnet

6.0

30.7

C88.9

ICD-10 Finland

Malignant immunoproliferative disease, unspecified

110.9

30.7

Z52.89

ICD-10 Finland

Donor of other organ or tissue

46.6

30.6

C83.70

ICD-10 Finland

Non-Hodgkin's lymphoma of the Burkitt type

+∞

30.2

D37.2

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Small intestine

6.8

30.1

A79

ICPC

Malignancy NOS

3.5

29.8

105

309

L01BB05

ATC

fludarabine; systemic

28.8

29.8

399

Kela drug reimbursment

Venetoclax

10.7

29.5

9591/3-C77.4

ICD-O-3

Malignant lymphoma, non-Hodgkin, NOS, of lymph nodes of inguinal region or leg

+∞

29.2

JMA11

NOMESCO Finland

Laparoscopic total splenectomy

11.6

29.1

OAB73

NOMESCO Finland

Prevention and treatment of malnutrition

4.3

29.0

173

9690/3-C77.9

ICD-O-3

Follicular lymphoma, NOS, of lymph node, NOS

40.4

29.0

N02BE01

ATC

paracetamol; systemic, rectal

1.7

28.9

3474

31767

JAL01

NOMESCO Finland

Laparoscopic biopsy of peritoneum

10.4

28.9

YX9AD

NOMESCO Finland

Other CT eamination for dose design of radiotherapy

2.9

28.9

139

493

D48.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Neoplasm of uncertain or unknown behaviour, unspecified

3.3

28.8

107

326

TNE20

NOMESCO Finland

Bone marrow aspiration, pelvis

11.2

28.4

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.5

28.4

1002

7131

R22.0

ICD-10 Finland

Localized swelling, mass and lump, head

2.6

28.3

165

646

I80.8

ICD-10 Finland

Phlebitis and thrombophlebitis of other sites

3.7

28.2

239

9680/3-C17.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of small intestine, NOS

+∞

28.2

A41.8

ICD-10 Finland

Other specified sepsis

3.0

27.6

121

407

120

Kela drug reimbursment

Hypogammaglobulinaemia

25.6

27.4

D37.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Digestive organ, unspecified

6.4

27.3

OAA41

NOMESCO Finland

Health check based on individual needs

7.4

27.1

C83.40

ICD-10 Finland

Immunoblast large cell lymphoma

+∞

27.1

N13.3

ICD-10 Finland

Other and unspecified hydronephrosis

2.9

27.1

127

444

Z51.3

ICD-10 Finland

Blood transfusion (without reported diagnosis)

38.1

27.1

J02AC01

ATC

fluconazole; systemic

1.5

27.0

1187

8831

EE1AA

NOMESCO Finland

X-ray of upper jaw or palate

8.4

27.0

9698/3-C77.9

ICD-O-3

Follicular lymphoma, grade 3 of lymph node, NOS

75.7

26.8

CFA20

NOMESCO Finland

Biopsy of conjunctiva

9.8

26.8

G62.0

ICD-10 Finland

Drug-induced polyneuropathy

8.2

26.5

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

2.0

26.2

320

1702

9679/3-C38.3

ICD-O-3

Mediastinal large B-cell lymphoma of mediastinum, NOS

+∞

26.1

9680/3-C42.2

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of spleen

+∞

26.1

J06BA01

ATC

immunoglobulins, normal human, for extravascular adm.; systemic

23.3

26.1

GA4AT

NOMESCO Finland

Cathetrisation of pleural cavity with ultrasound guidance

3.6

26.0

248

D37.00

ICD-10 Finland

Aryepiglottic fold marginal zone

7.5

25.9

JN4KR

NOMESCO Finland

Whole body very extensive metabolic PET with CT

5.4

25.7

1518, ,

Kela drug reimbursment

10.1

25.6

Z2446

NOMESCO Finland

Social worker

2.1

25.5

253

1248

R19.0

ICD-10 Finland

Intra-abdominal and pelvic swelling, mass and lump

3.2

25.4

104

336

9699/3-C34.9

ICD-O-3

Marginal zone B-cell lymphoma, NOS, of lung, NOS

+∞

25.0

9680/3-C77.4

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of lymph nodes of inguinal region or leg

+∞

25.0

J01DB01

ATC

cefalexin; oral

1.5

25.0

3107

27909

PJ2HT

NOMESCO Finland

Biopsy of deep lymphnode with ultrasound guidance

58.4

25.0

C80.99

ICD-10 Finland

Malignant tumor without specified localization or histology

9.7

25.0

C91.0

ICD-10 Finland

Acute lymphoblastic leukaemia [ALL]

21.4

24.7

9680/3-C49.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of connective, Subcutaneous and other soft tissues, NOS

251.7

24.7

9680/3-C34.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of lung, NOS

251.7

24.7

TDM10

NOMESCO Finland

Puncture of maxillary antrum

2.6

24.7

151

606

JAH00

NOMESCO Finland

Laparotomy

2.6

24.3

141

551

9699/3-C77.8

ICD-O-3

Marginal zone B-cell lymphoma, NOS, of lymph nodes of multiple regions

+∞

24.0

OAB38

NOMESCO Finland

Psychosocial guidance and counselling

7.2

23.7

PA7ST

NOMESCO Finland

Extensive medical infusion to cerebral artery

241.4

23.7

4701

FHL

Neck lymph node removal

19.6

23.4

WE300

NOMESCO Finland

Profylactive therapy of malignancy with biomoidiers

47.0

23.3

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

2.3

23.2

181

811

B02

ICPC

Lymph gland(s) enlarged/painful

5.1

23.0

9680/3-C22.0

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of liver

+∞

22.9

C88.4

ICD-10 Finland

Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lyphoma]

+∞

22.9

EP1CG

NOMESCO Finland

Extensive MRI examination of soft tissue of neck with high intesity magnet

3.8

22.8

188

PA4AC

NOMESCO Finland

Vertebralis angiography with X-ray

9.4

22.6

1CX01, ,

NOMESCO Finland

19.0

22.5

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

2.5

22.4

137

550

B03XA02

ATC

darbepoetin alfa; parenteral

2.7

22.2

118

442

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

1.7

22.1

414

2509

ZX121

NOMESCO Finland

Central venous catheter

7.1

22.0

Z2221

NOMESCO Finland

Medical doctor

1.5

22.0

970

7168

9680/3-C77.3

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of lymph nodes of axilla or arm

+∞

21.9

9673/3-C09.9

ICD-O-3

Mantle cell lymphoma of tonsil, NOS

+∞

21.9

1BC01, ,

NOMESCO Finland

+∞

21.9

YX9BD

NOMESCO Finland

Other extensive CT eamination for dose design of radiotherapy

4.5

21.7

120

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

2.3

21.7

173

783

JAH21

NOMESCO Finland

Staging laparoscopy

80.6

21.7

9699/3-C42.1

ICD-O-3

Marginal zone B-cell lymphoma, NOS, of bone marrow

80.6

21.7

J84.9

ICD-10 Finland

Interstitial pulmonary disease, unspecified

2.7

21.5

117

443

N02AX02

ATC

tramadol; systemic, rectal

1.4

21.5

1667

13605

JAH01

NOMESCO Finland

Laparoscopy

2.3

21.2

158

694

D43.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Central nervous system, unspecified

9.0

21.2

C82.7

ICD-10 Finland

Other types of follicular lymphoma

50.3

21.1

R4190

NOMESCO Finland

Nutritional therapy

2.3

20.9

156

686

9680/3-C49.0

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of connective, Subcutaneous and other soft tissues of head, face, and neck

+∞

20.8

Z51.0

ICD-10 Finland

Radiotherapy session

3.3

20.7

240

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

1.9

20.7

262

1409

Z01.8

ICD-10 Finland

Other specified special examinations

1.5

20.7

843

6126

9591/3-C16.9

ICD-O-3

Malignant lymphoma, non-Hodgkin, NOS, of stomach, NOS

211.1

20.6

9591/3-C09.9

ICD-O-3

Malignant lymphoma, non-Hodgkin, NOS, of tonsil, NOS

110.6

20.6

Z3231

NOMESCO Finland

Registered nurse

1.4

20.5

1036

7837

C84.49

ICD-10 Finland

Peripheral T-cell lymphoma, unspecified cell type

41.9

20.4

ZXE10

NOMESCO Finland

More than one and less than three hours

1.4

20.4

1334

10558

CAA30

NOMESCO Finland

Biopsy of orbit

22.5

20.3

9690/3-C77.8

ICD-O-3

Follicular lymphoma, NOS, of lymph nodes of multiple regions

+∞

19.8

9699/3-C07.9

ICD-O-3

Marginal zone B-cell lymphoma, NOS, of parotid gland

+∞

19.8

C83.7

ICD-10 Finland

Burkitt lymphoma

+∞

19.8

C83.52

ICD-10 Finland

T-lymphoblastic lymphoma or leukemia

+∞

19.8

R50.8

ICD-10 Finland

Other specified fever

5.1

19.7

XW1AT

NOMESCO Finland

Biopsy from other organ close to skin with ultrasound quidance

5.1

19.7

EB1CI

NOMESCO Finland

Cone beam imaging of teeth and jaws (3-4 quarters)

3.7

19.7

165

D73.1

ICD-10 Finland

Hypersplenism

29.1

19.6

C81.3

ICD-10 Finland

Lymphocyte depleted classical Hodgkin lymphoma

201.0

19.6

ENA10

NOMESCO Finland

Biopsy of pharynx

7.1

19.5

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.4

19.4

1235

9712

B01AB04

ATC

dalteparin; parenteral

2.0

19.4

215

1105

N03AX16

ATC

[U] pregabalin

1.5

19.4

851

6264

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

2.7

19.3

105

398

XW4CT

NOMESCO Finland

Biopsy of other inner organ with CT guidance

31.4

19.2

A05AA02

ATC

ursodeoxycholic acid; oral

3.5

19.2

192

EMB10

NOMESCO Finland

Tonsillectomy

2.5

19.2

126

524

PA3AC

NOMESCO Finland

Carotis angiography with X-ray

5.9

19.1

UJF32

NOMESCO Finland

Coloscopy

1.4

19.1

1046

8011

J01MA02

ATC

ciprofloxacin; systemic

1.4

19.1

1526

12444

EP2AT

NOMESCO Finland

Neck soft tissue cytology with ultrasound guidance

7.2

19.1

JA1AE

NOMESCO Finland

Ultrasound examination of groin and abdominal wall

2.7

19.0

102

384

D37.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Stomach

4.3

19.0

116

J01CA04

ATC

amoxicillin; systemic

1.4

18.9

2924

26410

7856A

ICD-9 Finland

Symptoms involving cardiovascular system, Enlargement of lymph nodes

14.9

18.9

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

3.0

18.8

281

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.4

18.8

1395

11237

C81.2

ICD-10 Finland

Mixed cellularity classical Hodgkin lymphoma

23.8

18.6

C81.7

ICD-10 Finland

Other classical Hodgkin lymphoma

20.9

18.6

WB401

NOMESCO Finland

Simple antibody therapy of primary tumour

4.0

18.6

131

ZX080

NOMESCO Finland

Image guided radiotherapy

2.7

18.6

101

383

C85.0

ICD-10 Finland

Lymphosarcoma

100.5

18.6

J84.8

ICD-10 Finland

Other specified interstitial pulmonary diseases

3.3

18.6

211

Z08.7

ICD-10 Finland

Follow-up examination after combined treatment for malignant neoplasm

4.2

18.4

119

ZXD10

NOMESCO Finland

Scheduled procedure

1.4

18.4

1376

11089

WPA13

NOMESCO Finland

Palliative consultation

5.1

18.3

9698/3-C77.8

ICD-O-3

Follicular lymphoma, grade 3 of lymph nodes of multiple regions

44.2

18.2

B74

ICPC

Malignant neoplasm blood other

13.6

18.2

GD6AD

NOMESCO Finland

CT of chest and neck

5.6

18.2

WX002

NOMESCO Finland

Sedation and analgesia

1.5

18.0

740

5370

D11.0

ICD-10 Finland

Benign neoplasm: Parotid gland

2.8

18.0

316

Z31.6

ICD-10 Finland

General counselling and advice on procreation

7.3

17.8

D80.9

ICD-10 Finland

Immunodeficiency with predominantly antibody defects, unspecified

18.1

17.8

9591/3-C77.1

ICD-O-3

Malignant lymphoma, non-Hodgkin, NOS, of intrathoracic lymph nodes

+∞

17.7

C83.5

ICD-10 Finland

Lymphoblastic (diffuse) lymphoma

+∞

17.7

9680/3-C49.2

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of connective, Subcutaneous and other soft tissues of lower limb and hip

+∞

17.7

9680/3-C50.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of breast, NOS

+∞

17.7

9680/3-C18.0

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of cecum

+∞

17.7

C83.6

ICD-10 Finland

Undifferentiated (diffuse) non-Hodgkin's lymphoma

+∞

17.7

9591/3-C42.1

ICD-O-3

Malignant lymphoma, non-Hodgkin, NOS, of bone marrow

66.9

17.7

TPW99

NOMESCO Finland

Other minor surgical procedure on peripheral vessel or lymphatic system

3.5

17.5

174

A07AA09

ATC

vancomycin; oral

3.0

17.4

251

9101

FHL

Bone biopsy

17.0

17.4

WX882

NOMESCO Finland

High dependency care

2.3

17.3

128

561

ELB30

NOMESCO Finland

Excision of submandibular gland

4.7

17.3

L04AD01

ATC

ciclosporin; systemic

3.0

17.2

263

C91.9

ICD-10 Finland

Lymphoid leukaemia, unspecified

12.6

17.1

J35.1

ICD-10 Finland

Hypertrophy of tonsils

4.1

17.0

113

NK1AT

NOMESCO Finland

Muscle biopsy with ultrasound guidance

7.5

17.0

D43.2

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Brain, unspecified

7.5

17.0

UDQ12

NOMESCO Finland

Flexible laryngoscopy

1.9

16.9

218

1180

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.8

16.8

284

1670

L04AA06

ATC

mycophenolic acid; systemic

2.8

16.8

289

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.5

16.7

627

4465

N03AX14

ATC

levetiracetam; systemic

2.4

16.6

119

515

9591/3-C77.3

ICD-O-3

Malignant lymphoma, non-Hodgkin, NOS, of lymph nodes of axilla or arm

90.5

16.6

C82

ICD-10 Finland

Follicular lymphoma

90.5

16.6

C80.90

ICD-10 Finland

Malignant tumor without specified localization without histology

7.0

16.5

9823/3-C77.8

ICD-O-3

B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of lymph nodes of multiple regions

170.7

16.5

ZX114

NOMESCO Finland

Intramuscular

3.3

16.4

192

TQW99

NOMESCO Finland

Other minor procedure on skin

1.9

16.4

221

1214

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

3.7

16.4

139

WF099

NOMESCO Finland

Other radiotherapy

4.5

16.3

372

Kela drug reimbursment

Idelalisib

40.2

16.3

R4110

NOMESCO Finland

Physiotherapy

1.4

16.3

1036

8102

TGE00

NOMESCO Finland

Needle biopsy of mediastinum

5.3

16.1

D37.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

2.3

16.0

123

549

A41.1

ICD-10 Finland

Sepsis due to other specified staphylococcus

3.7

15.8

138

JM2AT

NOMESCO Finland

Biopsy of spleen with ultrasound guidance

+∞

15.6

9699/3-C69.0

ICD-O-3

Marginal zone B-cell lymphoma, NOS, of conjunctiva

+∞

15.6

ZXX04

NOMESCO Finland

Extent of procedure, 4 units

6.0

15.6

C84.51

ICD-10 Finland

Other and unspecified T-cell lymphomas

26.4

15.6

C82.0

ICD-10 Finland

Follicular lymphoma grade I

85.4

15.6

A06AD11

ATC

lactulose; oral

1.5

15.5

621

4470

9591/3-C77.8

ICD-O-3

Malignant lymphoma, non-Hodgkin, NOS, of lymph nodes of multiple regions

160.6

15.5

9680/3-C38.3

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of mediastinum, NOS

160.6

15.5

TK800

NOMESCO Finland

Hemodialysis

2.5

15.4

396

J12.8

ICD-10 Finland

Other viral pneumonia

3.7

15.4

131

I42.7

ICD-10 Finland

Cardiomyopathy due to drugs and other external agents

38.2

15.4

G53.0

ICD-10 Finland

Postzoster neuralgia

3.9

15.4

113

AAB10

NOMESCO Finland

Partial excision of intracranial lesion

3.7

15.3

127

XX2RW, ,

NOMESCO Finland

3.0

15.1

228

TPH07

NOMESCO Finland

Cathetrisation of artery

1.5

15.1

473

3239

WD325

NOMESCO Finland

Demanding therapy of methastized malignancy with biomodifiers

3.1

15.1

202

QX4AT

NOMESCO Finland

Ultrsound guided needle biopsy of skin

5.6

15.1

PJ2CT

NOMESCO Finland

Biopsy of lymphnode with CT guidance

45.2

15.1

YN7AD

NOMESCO Finland

CT examination of spine for dose design of radiotherapy

5.1

15.0

GD6BD

NOMESCO Finland

Extensive CT of chest and neck

10.8

15.0

R93.8

ICD-10 Finland

Abnormal findings on diagnostic imaging of other specified body structures

4.6

14.9

KA3AT

NOMESCO Finland

Biopsy of kidney with ultrasound guidance

2.9

14.9

252

L04AA01

ATC

[U] ciclosporin

3.2

14.8

189

C84.43

ICD-10 Finland

Peripheral T-cell lymphoma, large cell type

56.9

14.8

B99

ICD-10 Finland

Other and unspecified infectious diseases

2.5

14.8

356

D59.1

ICD-10 Finland

Other autoimmune haemolytic anaemias

5.0

14.8

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

2.0

14.7

165

852

EBA15

NOMESCO Finland

Extraction of multiple teeth

2.0

14.7

167

866

WZC15, ,

NOMESCO Finland

3.6

14.6

131

9699/3-C69.6

ICD-O-3

Marginal zone B-cell lymphoma, NOS, of orbit, NOS

+∞

14.6

ZXD05

NOMESCO Finland

Urgent procedure

1.3

14.5

1050

8349

D10.4

ICD-10 Finland

Benign neoplasm: Tonsil

5.4

14.5

J94.8

ICD-10 Finland

Other specified pleural conditions

2.6

14.4

325

K63.1

ICD-10 Finland

Perforation of intestine (nontraumatic)

3.2

14.4

177

WVA20

NOMESCO Finland

Medicine administration

2.2

14.3

117

536

WPB10

NOMESCO Finland

Making a convalescent care decision

4.7

14.2

GAA10

NOMESCO Finland

Intercostal insertion of pleural drainage tube

2.5

14.2

375

EB1BA

NOMESCO Finland

Extensive intraoral X-ray examination

5.3

14.2

EP1DG

NOMESCO Finland

Very extensive examination of soft tissue of neck with high intesity magnet

4.1

14.2

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

1.8

14.2

231

1345

YL1BD

NOMESCO Finland

Extensive CT examination of pelvis for dose design of radiotherapy

2.3

14.1

106

469

A02BC01

ATC

omeprazole; systemic

1.3

14.0

995

7882

ZXC95

NOMESCO Finland

Use of surgical navigator

3.1

14.0

185

YL1AD

NOMESCO Finland

CT examination of pelvis for dose design of radiotherapy

2.4

13.9

422

I50.1

ICD-10 Finland

Left ventricular failure

1.7

13.8

230

1348

BA3AT

NOMESCO Finland

Cytology of thyroid with ultrasound quidance

2.7

13.8

263

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.4

13.6

666

4964

2002A

ICD-9 Finland

Lymphosarcoma and reticulosarcoma, Burkitt's tumour or lymphoma

+∞

13.5

9680/3-C30.0

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of nasal cavity

+∞

13.5

9680/3-C17.2

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of ileum

+∞

13.5

9695/3-C77.8

ICD-O-3

Follicular lymphoma, grade 1 of lymph nodes of multiple regions

140.5

13.5

C10AA07

ATC

rosuvastatin; oral

0.7

13.4

825

10445

R2120

NOMESCO Finland

Counselling and guidance concerning rehabilitation services and social security

3.7

13.3

111

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

1.8

13.3

216

1256

L01AA01

ATC

cyclophosphamide; systemic

4.5

13.3

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

2.2

13.2

105

477

ZXX01

NOMESCO Finland

Extent of proceudre, 1 unit

4.2

13.1

EB1JA

NOMESCO Finland

Double panorama tomography of teeth and jaws or similar X-ray examination

4.0

13.1

D69.3

ICD-10 Finland

Idiopathic thrombocytopenic purpura

3.8

13.1

103

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

2.6

13.1

287

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

1.7

13.1

262

1613

B37.09

ICD-10 Finland

Unspecified candidal stomatitis

3.2

13.1

156

T88.7

ICD-10 Finland

Unspecified adverse effect of drug or medicament

2.7

13.0

254

QAA05

NOMESCO Finland

Incision for biopsy of skin of head or neck

2.2

13.0

113

532

CKA10

NOMESCO Finland

Biopsy of vitreous body

10.1

12.9

ZYC01

NOMESCO Finland

Remote contact by phone

1.8

12.9

210

1222

KA1AE

NOMESCO Finland

Kidney ultrasound examination

2.2

12.9

111

520

EP1AE, ,

SPAT

2.8

12.9

238

L98.9

ICD-10 Finland

Disorder of skin and subcutaneous tissue, unspecified

2.9

12.9

216

YX9AW, ,

NOMESCO Finland

4.0

12.9

ZXA00

NOMESCO Finland

Right side

1.3

12.8

987

7900

JAL00

NOMESCO Finland

Biopsy of peritoneum

5.1

12.7

EL4AT

NOMESCO Finland

Salivary gland cytology with ultrasound guidance

4.8

12.6

JN5KR

NOMESCO Finland

Very extensive PET-CT of upper body metabolism (eyebrows to thighs)

5.5

12.6

CA1BG

NOMESCO Finland

Eye and orbita MRI examination with high intensity magnet

5.5

12.6

SAA03

NOMESCO Finland

Extended examination of mouth

1.3

12.5

1216

10043

XF400

NOMESCO Finland

ECG with 12 standard connections

1.4

12.5

608

4523

9680/3-C49.6

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of connective, Subcutaneous and other soft tissues of trunk, NOS

+∞

12.5

C83.41

ICD-10 Finland

Immunoblastic (diffuse)

+∞

12.5

9680/3-C41.4

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of pelvic bones, sacrum, coccyx and associated joints

+∞

12.5

9680/3-C49.3

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of connective, Subcutaneous and other soft tissues of thorax

+∞

12.5

1DB01, ,

NOMESCO Finland

+∞

12.5

9691/3-C77.8

ICD-O-3

Follicular lymphoma, grade 2 of lymph nodes of multiple regions

20.1

12.4

166

Kela drug reimbursment

Dalteparin and tinzaparin (treatment for more than 6 months)

3.2

12.4

151

9670/3-C77.9

ICD-O-3

Malignant lymphoma, small B lymphocytic, NOS, of lymph node, NOS

130.4

12.4

R05

ICD-10 Finland

Cough

1.4

12.4

737

5667

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

3.1

12.4

167

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.5

12.4

365

2466

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.7

12.3

231

1399

D86.0

ICD-10 Finland

Sarcoidosis of lung

3.1

12.2

168

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.4

12.2

650

4907

A03

ICPC

Fever

1.5

12.2

480

3434

YN1AD

NOMESCO Finland

CT examination of extremities for dose design of radiotherapy

9.7

12.2

L01XX47

ATC

[U] idelalisib

37.6

12.2

C92.0

ICD-10 Finland

Acute myeloblastic leukaemia [AML]

4.4

12.1

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.7

12.1

224

1351

WPA10

NOMESCO Finland

Proactive palliative care treatment plan

3.2

12.0

149

R59

ICD-10 Finland

Enlarged lymph nodes

21.3

12.0

PA7RT

NOMESCO Finland

Medical infusion to cerebral artery

21.3

12.0

YG1AD

NOMESCO Finland

CT examination of thorax for dose design of radiotherapy

2.3

12.0

412

C71.99

ICD-10 Finland

Malignant tumor in unspecified localization in the brain other or unspecified histology

13.4

11.9

WX892

NOMESCO Finland

Monitored bed care

1.6

11.8

295

1920

D73.9

ICD-10 Finland

Disease of spleen, unspecified

30.1

11.6

A04AA55

ATC

palonosetron, combinations; systemic

2.0

11.6

116

576

N05BA06

ATC

lorazepam; systemic, sublingual

1.7

11.6

196

1153

I42.0

ICD-10 Finland

Dilated cardiomyopathy

2.1

11.6

113

556

C81

ICD-10 Finland

Hodgkin lymphoma

65.1

11.6

ZX100

NOMESCO Finland

Oral

2.6

11.6

246

D37.08

ICD-10 Finland

Tumor of uncertain or unknown nature in other part of lip, oral cavity and pharynx

5.3

11.5

6BA02, ,

NOMESCO Finland

9.2

11.5

9680/3-C48.0

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of retroperitoneum

+∞

11.5

9680/3-C17.0

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of duodenum

+∞

11.5

9687/3-C77.9

ICD-O-3

Burkitt lymphoma, NOS, of lymph node, NOS

+∞

11.5

9699/3-C08.0

ICD-O-3

Marginal zone B-cell lymphoma, NOS, of submandibular gland

+∞

11.5

9699/3-C44.9

ICD-O-3

Marginal zone B-cell lymphoma, NOS, of skin, NOS

+∞

11.5

9688/3-C77.9

ICD-O-3

T-cell/histiocyte rich large B-cell lymphoma of lymph node, NOS

+∞

11.5

H26.3

ICD-10 Finland

Drug-induced cataract

4.0

11.5

D48.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Connective and other soft tissue

2.5

11.5

301

2019X

ICD-9 Finland

Hodgkin's disease, unspecified

120.4

11.4

B00.19

ICD-10 Finland

Other vesicular dermatitis caused by the herper simplex virus

4.0

11.4

J01FF01

ATC

clindamycin; systemic

1.3

11.3

919

7392

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.4

11.2

509

3736

D31.6

ICD-10 Finland

Benign neoplasm: Orbit, unspecified

10.5

11.2

D47.2

ICD-10 Finland

Monoclonal gammopathy of undetermined significance (MGUS)

2.7

11.2

227

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

1.8

11.2

151

831

D04.5

ICD-10 Finland

Carcinoma in situ: Skin of trunk

2.8

11.2

194

A49.8

ICD-10 Finland

Other bacterial infections of unspecified site

3.2

11.1

136

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

1.7

11.1

183

1071

B73

ICPC

Leukaemia

8.6

11.0

J70.2

ICD-10 Finland

Acute drug-induced interstitial lung disorders

5.7

11.0

ZX130

NOMESCO Finland

Epidural

5.7

11.0

YN1BD

NOMESCO Finland

Extensive CT examination of extremities for dose design of radiotherapy

9.2

11.0

ZXA05

NOMESCO Finland

Left side

1.3

11.0

891

7162

A02BA02

ATC

ranitidine; systemic

1.3

10.9

701

5444

GCA98

NOMESCO Finland

Other bronchoscopic procedure on bronchus

3.3

10.9

122

9663/3-C77.8

ICD-O-3

Hodgkin lymphoma, nodular sclerosis, NOS, of lymph nodes of multiple regions

43.4

10.9

B03XA01

ATC

erythropoietin; parenteral

3.0

10.9

153

SPAT1153

SPAT

Removal of sutures

1.3

10.8

1171

9771

D80.3

ICD-10 Finland

Selective deficiency of immunoglobulin G [IgG] subclasses

11.9

10.8

XX1AD

NOMESCO Finland

Other CT-examination

3.3

10.8

118

EBA10

NOMESCO Finland

Operative extraction of tooth

1.5

10.8

335

2287

UJF30

NOMESCO Finland

Ileoscopy through colon

1.5

10.8

369

2570

A04AD12

ATC

aprepitant; systemic

2.4

10.7

293

C84.41

ICD-10 Finland

Peripheral T-cell lymphoma, medium-sized cell type

60.2

10.6

HA1AA

NOMESCO Finland

X-ray mammography

1.6

10.6

246

1574

L57.0

ICD-10 Finland

Actinic keratosis

1.4

10.6

451

3274

9691/3-C77.0

ICD-O-3

Follicular lymphoma, grade 2 of lymph nodes of head, face and neck

110.3

10.4

AAF30

NOMESCO Finland

Implantation of intraventricular injection device

110.3

10.4

9680/3-C44.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of skin, NOS

+∞

10.4

9690/3-C77.0

ICD-O-3

Follicular lymphoma, NOS, of lymph nodes of head, face and neck

+∞

10.4

C88.7

ICD-10 Finland

Other malignant immunoproliferative diseases

+∞

10.4

9680/3-C41.2

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of vertebral column

+∞

10.4

9690/3-C42.1

ICD-O-3

Follicular lymphoma, NOS, of bone marrow

+∞

10.4

S04

ICPC

Lump/swelling localized

1.5

10.4

353

2454

D89.89

ICD-10 Finland

Other specified disorders involving the immune mechanism, not elsewhere classified

32.6

10.3

R11

ICD-10 Finland

Nausea and vomiting

1.5

10.2

292

1961

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.3

10.1

786

6271

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.3

10.1

914

7443

WX704

NOMESCO Finland

Intubation

1.5

10.1

277

1843

A06AH03

ATC

naloxegol; oral

2.4

10.0

271

PJD43

NOMESCO Finland

Excision of aortic lymph nodes

10.0

9671/3-C42.1

ICD-O-3

Lymphoplasmacytic lymphoma of bone marrow

40.2

10.0

ZYC03

NOMESCO Finland

Remote contact, text-based

3.8

9.9

A40.8

ICD-10 Finland

Other streptococcal sepsis

2.7

9.9

190

QBA25

NOMESCO Finland

Destruction of lesion of skin of trunk

2.2

9.9

387

R53

ICD-10 Finland

Malaise and fatigue

1.3

9.9

842

6803

9761/3-C42.0

ICD-O-3

Waldenstrom macroglobulinemia of blood

10.6

9.8

P01BA02

ATC

hydroxychloroquine; oral

1.6

9.7

257

1695

B99

ICPC

Blood/lymph/spleen disease other

4.1

9.7

KBV02

NOMESCO Finland

Cystoscopic insertion of stent into ureter

2.0

9.6

491

C44.31

ICD-10 Finland

Basocellular carcinoma of the skin on another or unspecified part of the face

1.5

9.6

287

1942

2015X

ICD-9 Finland

Hodgkin's disease, Nodular sclerosis[MORBUS HODGKIN, NODULAR SCLEROSIS, NUD]

55.1

9.6

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

1.8

9.6

140

791

R93.3

ICD-10 Finland

Abnormal findings on diagnostic imaging of other parts of digestive tract

3.7

9.6

P01AB01

ATC

metronidazole; oral, rectal

1.3

9.6

1249

10628

EP1BG

NOMESCO Finland

MRI examination of soft tissue of neck with high intesity magnet

4.4

9.5

WX199

NOMESCO Finland

Other local analgesia

1.8

9.5

135

756

I82.88

ICD-10 Finland

Embolism and thrombosis of other specified veins

2.2

9.5

341

NK6BN

NOMESCO Finland

Bone dynamic isotope examination

7.1

9.5

RS220, ,

NOMESCO Finland

2.8

9.4

172

YG1BD

NOMESCO Finland

Extensive CT examination of thorax for dose design of radiotherapy

1.9

9.4

115

614

3AX16, ,

NOMESCO Finland

100.3

9.4

9705/3-C77.9

ICD-O-3

Angioimmunoblastic T-cell lymphoma of lymph node, NOS

100.3

9.4

JA3HT

NOMESCO Finland

Tissue sample of abdominal tissue change under UA control

30.1

9.4

1CA02, ,

NOMESCO Finland

+∞

9.4

9673/3-C80.9

ICD-O-3

Mantle cell lymphoma of unknown primary site

+∞

9.4

9689/3-C42.1

ICD-O-3

Splenic marginal zone B-cell lymphoma of bone marrow

+∞

9.4

9680/3-C64.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of kidney, NOS

+∞

9.4

9680/3-C11.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of nasopharynx, NOS

+∞

9.4

9699/3-C80.9

ICD-O-3

Marginal zone B-cell lymphoma, NOS, of unknown primary site

+∞

9.4

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.2

9.4

343

T86.0

ICD-10 Finland

Bone-marrow transplant rejection

12.4

9.3

9663/3-C77.9

ICD-O-3

Hodgkin lymphoma, nodular sclerosis, NOS, of lymph node, NOS

21.7

9.3

Z51.88

ICD-10 Finland

Other specified medical care

2.1

9.3

389

R93.5

ICD-10 Finland

Abnormal findings on diagnostic imaging of other abdominal regions, including retroperitoneum

2.7

9.3

185

D43.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Brain, infratentorial

9.5

9.3

OAB74

NOMESCO Finland

Nutritional guidance related to treatment and rehabilitation for medical condition

2.7

9.2

180

TPH40

NOMESCO Finland

Insertion of a long peripheral venous catheter

3.0

9.2

136

AA1AD

NOMESCO Finland

CT of head and brain

1.3

9.1

1142

9657

M80.4

ICD-10 Finland

Drug-induced osteoporosis with pathological fracture

3.6

9.1

EB1BI

NOMESCO Finland

Cone beam imaging of teeth and jaws (1–2 quarters)

2.3

9.1

271

D41.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Kidney

1.9

9.1

113

608

2390A

ICD-9 Finland

Neoplasm of unspecified nature, Digestive system

4.8

9.1

NA2CG

NOMESCO Finland

Thoracal spine extensive MRI examination with high intensity magnet

3.0

9.0

132

B34.9

ICD-10 Finland

Viral infection, unspecified

2.1

8.9

376

D86.2

ICD-10 Finland

Sarcoidosis of lung with sarcoidosis of lymph nodes

3.1

8.9

112

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

2.2

8.9

344

I89.9

ICD-10 Finland

Noninfective disorder of lymphatic vessels and lymph nodes, unspecified

12.5

8.9

D11.70

ICD-10 Finland

Gland sublingual

4.9

8.8

D72.9

ICD-10 Finland

Disorder of white blood cells, unspecified

4.9

8.8

5702

FHL

Local lymph node removal (eg armpit, groin)

4.5

8.8

PJ4AT

NOMESCO Finland

Labeling lymphnode with ultrasound guidance

10.7

8.8

R22.7

ICD-10 Finland

Localized swelling, mass and lump, multiple sites

9.5

8.8

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

1.8

8.7

128

726

WX720

NOMESCO Finland

Own respiration

1.7

8.7

170

1044

C90.0

ICD-10 Finland

Multiple myeloma

2.4

8.6

228

WX302

NOMESCO Finland

Thoracal epidural anesthesy

1.6

8.6

190

1202

XX3AT

NOMESCO Finland

Other labeling with ultrasound guidance

3.7

8.6

JJ1CE

NOMESCO Finland

Liver, bile duct and pancreas endoscopic ultrasound examination

4.0

8.6

H05.9

ICD-10 Finland

Disorder of orbit, unspecified

16.3

8.5

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

1.5

8.5

252

1703

GDA11

NOMESCO Finland

Thoracoscopic biopsy of lung

4.1

8.5

Z08.9

ICD-10 Finland

Follow-up examination after unspecified treatment for malignant neoplasm

3.8

8.5

D73.0

ICD-10 Finland

Hyposplenism

27.6

8.5

9702/3-C77.9

ICD-O-3

Mature T-cell lymphoma, NOS, of lymph node, NOS

27.6

8.5

KH1BT

NOMESCO Finland

Urinary tract cathetrisation with X-ray guidance

2.4

8.5

230

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.5

8.4

263

1798

9591/3-C17.9

ICD-O-3

Malignant lymphoma, non-Hodgkin, NOS, of small intestine, NOS

90.3

8.4

J17.1*B25.0

ICD-10 Finland

Cytomegaloviral pneumonitis

90.3

8.4

9680/3-C25.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of pancreas, NOS

90.3

8.4

K11.2

ICD-10 Finland

Sialoadenitis

1.9

8.4

105

566

J01.4

ICD-10 Finland

Acute pansinusitis

3.5

8.4

WPA15

NOMESCO Finland

Palliative care consultation with the patient and loved ones

3.5

8.4

J38.0

ICD-10 Finland

Paralysis of vocal cords and larynx

2.2

8.3

288

9680/3-C07.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of parotid gland

+∞

8.3

9688/3-C77.8

ICD-O-3

T-cell/histiocyte rich large B-cell lymphoma of lymph nodes of multiple regions

+∞

8.3

9680/3-C49.4

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of connective, Subcutaneous and other soft tissues of abdomen

+∞

8.3

9670/3-C77.0

ICD-O-3

Malignant lymphoma, small B lymphocytic, NOS, of lymph nodes of head, face and neck

+∞

8.3

C83.4

ICD-10 Finland

Immunoblastic (diffuse) non-Hodgkin's lymphoma

+∞

8.3

9680/3-C16.2

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of body of stomach

+∞

8.3

9690/3-C77.4

ICD-O-3

Follicular lymphoma, NOS, of lymph nodes of inguinal region or leg

+∞

8.3

9680/3-C06.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of mouth, NOS

+∞

8.3

I10

ICD-10 Finland

Essential (primary) hypertension

0.8

8.3

2103

22954

CBA10

NOMESCO Finland

Biopsy of eyelid

2.7

8.3

161

121

Kela drug reimbursment

Severe hypofunction of sexual glands

2.3

8.3

257

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

2.0

8.3

435

J01AA02

ATC

doxycycline; systemic

1.2

8.3

2792

26086

JN3DE

NOMESCO Finland

Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation

4.1

8.2

CA1CM

NOMESCO Finland

Eye and orbita extensive MRI examination with 3 Tesla magnet

7.1

8.2

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.4

8.2

409

3048

B04

ICPC

Blood symptom/complaint

3.3

8.2

Z51.4

ICD-10 Finland

Preparatory care for subsequent treatment, not elsewhere classified

2.7

8.1

163

C69.60

ICD-10 Finland

Malignant tumor in orbit without histology

33.4

8.1

Z03.1

ICD-10 Finland

Observation for suspected malignant neoplasm

2.1

8.1

358

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.3

8.0

528

4109

R19.8

ICD-10 Finland

Other specified symptoms and signs involving the digestive system and abdomen

2.4

8.0

218

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

1.9

7.9

506

WPA45

NOMESCO Finland

Continuous drug infusion in palliative care

4.6

7.9

AA5DR

NOMESCO Finland

Brain metabolism PET with CT

7.8

7.9

WD505

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of methastized malignancy

2.5

7.8

190

D47.7

ICD-10 Finland

Other specified neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue

10.8

7.8

C91.7

ICD-10 Finland

Other lymphoid leukaemia

9.4

7.8

B00.11

ICD-10 Finland

Herpes simplex labialis

2.5

7.7

185

5701

FHL

Local exploration of lymph nodes (includes biopsy)

15.0

7.7

JAH20

NOMESCO Finland

Staging laparotomy

15.0

7.7

QBE99

NOMESCO Finland

Other excision or repair of lesion of skin of trunk

2.1

7.7

312

8070/3-C44.9

ICD-O-3

Squamous cell carcinoma, NOS, of skin, NOS

2.1

7.7

352

ZXC50

NOMESCO Finland

Cryotherapy

1.7

7.7

129

762

I50.9

ICD-10 Finland

Heart failure, unspecified

1.3

7.6

605

4827

WE100

NOMESCO Finland

Profylactic cytostatic therapy

18.4

7.6

EP3AT

NOMESCO Finland

Neck soft tissue biopsy with ultrasound guidance

11.9

7.6

JN4DD

NOMESCO Finland

Scout CT scan of torso

8.9

7.5

C44.32

ICD-10 Finland

Spinocellular carcinoma of the skin on another or unspecified part of the face

2.0

7.5

375

KBV15

NOMESCO Finland

Cystoscopic change of ureteral stent

3.1

7.4

KA3CT

NOMESCO Finland

Biopsy of kidney under CT guidance

80.2

7.4

9591/3-C62.9

ICD-O-3

Malignant lymphoma, non-Hodgkin, NOS, of testis, NOS

80.2

7.4

D86.1

ICD-10 Finland

Sarcoidosis of lymph nodes

3.5

7.4

Z94.1

ICD-10 Finland

Heart transplant status

6.5

7.4

1AA01, ,

NOMESCO Finland

13.4

7.4

D46.9

ICD-10 Finland

Myelodysplastic syndrome, unspecified

3.3

7.4

N17.9

ICD-10 Finland

Acute renal failure, unspecified

1.6

7.4

173

1113

FB1AD

NOMESCO Finland

CT examination of arteria pulmonalis

1.9

7.3

498

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

1.7

7.3

119

697

3AF07, ,

NOMESCO Finland

+∞

7.3

JM1AT

NOMESCO Finland

Cytology of spleen with ultrasound guidance

+∞

7.3

9680/3-C49.1

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of connective, Subcutaneous and other soft tissues of upper limb and shoulder

+∞

7.3

9680/3-C73.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of thyroid gland

+∞

7.3

D76.1

ICD-10 Finland

Haemophagocytic lymphohistiocytosis

+∞

7.3

9670/3-C77.8

ICD-O-3

Malignant lymphoma, small B lymphocytic, NOS, of lymph nodes of multiple regions

+∞

7.3

20013

ICD-8 Finland

Lymphosarcoma and reticulum-cell sarcoma, Lymphosarcoma loco alio (lymphonodis intrathoracalibus et intra-abdominalibus inclusis)

+∞

7.3

9680/3-C01.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of base of tongue, NOS

+∞

7.3

WYA00

NOMESCO Finland

Screening and health check-up

2.3

7.3

215

GD1CD

NOMESCO Finland

Thorax extensive CT-examination

2.6

7.3

149

D10.6

ICD-10 Finland

Benign neoplasm: Nasopharynx

6.8

7.3

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.2

7.3

1492

13214

M80.8

ICD-10 Finland

Other osteoporosis with pathological fracture

3.5

7.3

J12.1

ICD-10 Finland

Respiratory syncytial virus pneumonia

3.2

7.3

D86.9

ICD-10 Finland

Sarcoidosis, unspecified

3.2

7.3

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

1.7

7.2

122

721

XJD02

NOMESCO Finland

Peroral endoscopic ultrasonography

2.5

7.2

167

C84.5

ICD-10 Finland

Other mature T/NK-cell lymphomas

15.8

7.2

J94.0

ICD-10 Finland

Chylous effusion

15.8

7.2

B44.0

ICD-10 Finland

Invasive pulmonary aspergillosis

15.8

7.2

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

1.6

7.2

146

906

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

2.5

7.2

174

6103

FHL

Staging laparotomy (to study the reticuloendothelial system)

30.1

7.1

C38.3

ICD-10 Finland

Malignant neoplasm: Mediastinum, part unspecified

20.0

7.1

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.5

7.1

200

1339

WB123

NOMESCO Finland

Demanding adjuvant cytostatic therapy

2.6

7.1

157

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.4

7.1

290

2091

T80.8

ICD-10 Finland

Other complications following infusion, transfusion and therapeutic injection

8.8

7.0

D04.3

ICD-10 Finland

Carcinoma in situ: Skin of other and unspecified parts of face

1.8

7.0

534

N06DX01

ATC

memantine; oral

0.6

7.0

149

2307

KA3EB

NOMESCO Finland

Antegrade pyelography

3.1

7.0

E78.0

ICD-10 Finland

Pure hypercholesterolaemia

0.8

6.9

517

6458

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

1.4

6.9

323

2381

YA1CD

NOMESCO Finland

Very extensive CT examination of head and neck for dose design of radiotherapy

6.3

6.9

N02AJ06

ATC

codeine and paracetamol; systemic

1.2

6.9

1412

12484

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.3

6.9

485

3804

JF1CG

NOMESCO Finland

Extensive MRI of small bowel

3.7

6.9

ELB00

NOMESCO Finland

Excision or exploration of lesion of salivary gland

5.8

6.9

J02AC04

ATC

posaconazole; systemic

13.8

6.9

3AA02, ,

NOMESCO Finland

13.8

6.9

JN6CD

NOMESCO Finland

Very extensive CT of torso and neck

13.8

6.9

R07.0

ICD-10 Finland

Pain in throat

1.6

6.9

171

1115

D64.8

ICD-10 Finland

Other specified anaemias

2.0

6.9

374

ZXC40

NOMESCO Finland

Use of ultrasound

3.3

6.8

R22.2

ICD-10 Finland

Localized swelling, mass and lump, trunk

1.8

6.8

105

606

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.3

6.8

613

4970

Z94.0

ICD-10 Finland

Kidney transplant status

2.6

6.8

149

9591/3-C80.9

ICD-O-3

Malignant lymphoma, non-Hodgkin, NOS, of unknown primary site

40.1

6.8

2301

FHL

Lumbar puncture in anesthesia or operating room

40.1

6.8

NA7CG

NOMESCO Finland

Spine and spinal cord extensive MRI examination with high intensity magnet

2.4

6.8

173

B02

ICD-10 Finland

Zoster [herpes zoster]

1.6

6.7

153

977

A04AA03

ATC

tropisetron; systemic

4.3

6.7

9663/3-C77.0

ICD-O-3

Hodgkin lymphoma, nodular sclerosis, NOS, of lymph nodes of head, face and neck

16.7

6.7

WW302

NOMESCO Finland

Allogenic transfer of stem cells from relative

16.7

6.7

XX9BW

NOMESCO Finland

Submitting image material and/or investigation material to authority or other institution

2.2

6.7

249

NE1CG

NOMESCO Finland

Pelvic, hip and femur extensive MRI examination with high intensity magnet

2.0

6.6

337

WX725

NOMESCO Finland

Noninvasive ventilation

1.5

6.6

182

1214

ZYY98

NOMESCO Finland

Missed treatment contact, no notification given by patient

4.0

6.6

GD5BD

NOMESCO Finland

Thorax and upper abdomen combined extensive CT examination of

1.9

6.6

401

EL3AT

NOMESCO Finland

Salivary gland biopsy with ultrasound guidance

12.3

6.6

J70.4

ICD-10 Finland

Drug-induced interstitial lung disorders, unspecified

12.3

6.6

XX1XW

NOMESCO Finland

Extensive written report from radiologist

1.9

6.6

387

XFE00

NOMESCO Finland

Epicardial ultrasonography

1.9

6.6

451

SAA04

NOMESCO Finland

Special examination of mouth

1.6

6.5

147

938

EB1AI

NOMESCO Finland

Cone beam imaging of teeth and jaws (one quarter)

2.2

6.5

246

XG410

NOMESCO Finland

Flow-volume spirometry

1.6

6.5

133

829

J01.1

ICD-10 Finland

Acute frontal sinusitis

2.3

6.5

195

GA3AT

NOMESCO Finland

Pleural cytology with ultrasound guidance

3.6

6.5

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.5

6.5

205

1409

PJD99

NOMESCO Finland

Excision of other lymph nodes

6.2

6.5

C76.2

ICD-10 Finland

Malignant neoplasm of other and ill-defined sites: Abdomen

5.7

6.4

9591/3-C71.9

ICD-O-3

Malignant lymphoma, non-Hodgkin, NOS, of brain, NOS

70.0

6.4

1XX08, ,

NOMESCO Finland

70.0

6.4

9920/3-C42.1

ICD-O-3

Therapy-related myeloid neoplasm of bone marrow

70.0

6.4

C779, 9715, 3

ICD-O-3

70.0

6.4

A02BC05

ATC

esomeprazole; systemic

1.2

6.4

1350

11949

C10AX09

ATC

ezetimibe; oral

0.8

6.4

404

5162

201

Kela drug reimbursment

Chronic cardiac insufficiency

1.5

6.4

219

1530

D04.2

ICD-10 Finland

Carcinoma in situ: Skin of ear and external auricular canal

3.0

6.3

N74

ICPC

Malignant neoplasm nervous system

8.1

6.3

C07AB07

ATC

bisoprolol; oral

1.2

6.3

1921

17549

NA3DG

NOMESCO Finland

Lumbar spine very extensive MRI examination with high intensity magnet

2.9

6.3

EMA30

NOMESCO Finland

Biopsy of rhinopharynx

5.9

6.3

B37.08

ICD-10 Finland

Other candidal stomatitis

2.6

6.3

131

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

1.7

6.3

100

583

J35.9

ICD-10 Finland

Chronic disease of tonsils and adenoids, unspecified

9.3

6.3

J04BA02

ATC

dapsone; oral

3.5

6.3

NE1DG

NOMESCO Finland

Pelvic, hip and femur very extensive MRI examination with high intensity magnet

3.3

6.3

WF029

NOMESCO Finland

Radiotherapy of local residive tumor

2.7

6.3

114

Z31.8

ICD-10 Finland

Other procreative management

18.0

6.3

QXA50

NOMESCO Finland

Skin cryotherapy, unspecified location

2.9

6.3

1AD01, ,

NOMESCO Finland

+∞

6.2

9591/3-C06.9

ICD-O-3

Malignant lymphoma, non-Hodgkin, NOS, of mouth, NOS

+∞

6.2

9680/3-C62.1

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of descended testis

+∞

6.2

AAF35

NOMESCO Finland

Implantation of reservoir for intraventricular therapy

+∞

6.2

9673/3-C77.4

ICD-O-3

Mantle cell lymphoma of lymph nodes of inguinal region or leg

+∞

6.2

9673/3-C77.0

ICD-O-3

Mantle cell lymphoma of lymph nodes of head, face and neck

+∞

6.2

9673/3-C77.3

ICD-O-3

Mantle cell lymphoma of lymph nodes of axilla or arm

+∞

6.2

9673/3-C16.9

ICD-O-3

Mantle cell lymphoma of stomach, NOS

+∞

6.2

C85

ICD-10 Finland

Other and unspecified types of non-Hodgkin lymphoma

+∞

6.2

PJ023

NOMESCO Finland

Adjuvant radiotherapy of mediastinal lymphnodes

+∞

6.2

9680/3-C67.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of bladder, NOS

+∞

6.2

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

1.6

6.2

149

965

P20

ICPC

Memory disturbance

0.8

6.2

363

4688

M01CB01

ATC

sodium aurothiomalate; parenteral

2.3

6.2

193

J94.9

ICD-10 Finland

Pleural condition, unspecified

3.1

6.2

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

1.6

6.2

132

832

M84.4

ICD-10 Finland

Pathological fracture, not elsewhere classified

4.0

6.2

L04AX01

ATC

azathioprine; systemic

1.6

6.1

119

732

B28

ICPC

Limited function/disability (B)

3.2

6.1

JN3CG

NOMESCO Finland

Extensive MRI examination of abdomen with high intensity magnet

3.3

6.1

D04.4

ICD-10 Finland

Carcinoma in situ: Skin of scalp and neck

2.4

6.1

169

6753

FHL

Transabdominal splenectomy

7.7

6.1

OAB77

NOMESCO Finland

Discussion on exercise habits and instruction concerning use of sports and fitness services

7.7

6.1

NK1XE

NOMESCO Finland

Other ultrasound examinnation of muscle or tendon

2.6

6.1

133

I82.9

ICD-10 Finland

Embolism and thrombosis of unspecified vein

2.0

6.1

327

R81

ICPC

Pneumonia

1.6

6.1

128

803

C69.00

ICD-10 Finland

Malignant tumor of the conjunctiva without histology

12.5

6.1

C95.9

ICD-10 Finland

Leukaemia, unspecified

12.5

6.1

N06DA02

ATC

donepezil; oral

0.6

6.1

109

1753

JF1BD

NOMESCO Finland

Very extensive small bowel CT

3.1

6.0

D44.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Thyroid gland

2.2

6.0

208

Z08.2

ICD-10 Finland

Follow-up examination after chemotherapy for malignant neoplasm

10.0

6.0

D73.5

ICD-10 Finland

Infarction of spleen

6.7

6.0

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1673

6718

3.57

322.23

7.2

3.3

0.81

mmol/l

2.46

1622

6310

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

576

1011

6.49

321.14

2.2

1.5

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

3220

19603

4.36

316.72

17.0

6.8

10.99

12.27

umol/l

5.19

3183

18714

(3004809) Band form neutrophils/Leukocytes in Blood

464

673

7.67

309.38

5.1

3.6

1.72

1.68

0.08

445

590

(1175426) CD3 cells/Lymphocytes in Blood

550

205

30.97

307.65

2.3

1.9

73.44

70.38

1.53

527

190

(3042111) Morphology [Interpretation] in Bone marrow Narrative

896

668

17.02

307.65

1.8

1.6

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

561

191

34.03

307.65

2.4

1.9

—

(3006315) Basophils [#/volume] in Blood

3250

18170

5.30

307.65

11.8

6.2

0.04

e9/l

12.89

2954

15370

(3019069) Monocytes/Leukocytes in Blood

3141

16786

5.13

307.65

12.7

6.6

9.76

9.12

19.15

3076

15655

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1808

1989

15.82

307.65

1.4

—

(4035726) Immunohistochemistry procedure

1588

3249

7.47

307.65

1.8

1.4

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

595

1032

6.60

307.65

2.2

1.6

—

(3019198) Lymphocytes [#/volume] in Blood

3262

18467

5.24

307.65

12.0

6.3

1.86

1.88

e9/l

0.18

3011

16004

(3028026) IgM [Mass/volume] in Serum or Plasma

1072

2112

6.58

307.65

3.4

1.9

1.59

1.26

g/l

1.97

1015

1926

(46235355) HIV 1 and 2 tests - Meaningful Use set

2094

4123

9.61

307.65

1.6

1.7

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

399

184

23.99

307.65

2.9

2.2

575.72

485.91

e6/l

0.75

318

144

(3010503) CD19 cells [#/volume] in Blood

424

178

26.54

307.65

2.8

2.2

197.83

158.50

e6/l

0.24

417

168

(3007449) CD3+CD8+ (T8 suppressor) cells/cells in Blood

242

28.89

307.65

2.4

2.0

36.15

25.38

7.98

223

(3017143) Hepatitis C virus Ab [Presence] in Serum

1908

3099

10.90

307.65

1.5

1.6

—

(3011412) CD3 cells [#/volume] in Blood

655

263

29.61

307.65

2.7

2.1

1075.34

1113.34

e6/l

0.24

592

227

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

2030

3578

10.54

307.65

1.6

—

(40768795) Lymph node Pathology biopsy report

985

265

49.06

307.65

1.4

1.2

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

2772

4843

16.55

307.65

8.7

4.2

286.15

240.42

u/l

10.46

2714

4580

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

585

995

6.72

307.65

1.7

1.6

—

(3026493) Urate [Moles/volume] in Serum or Plasma

2573

9838

5.57

307.65

6.3

2.9

317.96

357.43

umol/l

61.25

2508

8499

(3005719) IgG [Mass/volume] in Serum or Plasma

1481

2642

8.33

307.65

4.5

2.8

8.81

10.77

g/l

33.71

1435

2419

(3027945) Reticulocytes/Erythrocytes in Blood

1466

5077

3.99

307.65

3.9

2.5

1.81

1.79

0.24

1387

4493

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

544

621

9.99

307.65

1.4

28.41

15.33

u/ml

—

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

405

170

26.41

307.65

3.6

2.4

33.37

40.27

3.63

285

(3027831) CD3-CD16+CD56+ (Natural killer) cells/cells in Blood

535

190

32.37

307.65

2.3

2.0

16.01

15.88

0.05

517

183

(21494814) CD8 cells/Lymphocytes in Specimen

312

112

30.14

307.65

2.2

1.9

40.27

28.58

11.75

312

112

(3017181) Myelocytes/Leukocytes in Blood

1146

3450

4.26

307.65

6.8

4.3

1.12

0.94

1.42

840

1069

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

374

191

21.51

307.65

3.2

2.1

0.45

0.68

e9/l

3.43

352

179

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

759

700

13.16

307.65

4.9

5.5

2209.17

655.39

iu/ml

0.42

126

(3002030) Lymphocytes/Leukocytes in Blood

3140

17033

4.99

307.65

12.6

6.5

26.90

26.41

1.22

3087

16063

(3006245) CD3-CD19+ cells/cells in Blood

241

29.09

307.65

2.4

1.9

10.80

11.75

0.18

211

(40765096) Chromosome analysis panel by Banding

294

105

30.15

307.65

1.2

1.1

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

379

307

13.54

307.65

1.6

1.8

3.90

4.56

mg/l

1.48

366

296

(3013115) Eosinophils [#/volume] in Blood

3274

18685

5.24

307.65

12.7

6.4

0.16

0.20

e9/l

28.10

3000

16050

(3018010) Neutrophils/Leukocytes in Blood

3089

16726

4.78

307.65

11.7

6.4

56.55

58.22

9.18

3047

15910

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

495

541

10.31

307.65

1.4

129.78

155.42

au/ml

2.97

138

165

(3006504) Eosinophils/Leukocytes in Blood

3131

16760

5.07

307.65

12.4

6.5

2.59

2.87

10.02

3069

15627

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

555

624

10.17

307.65

1.4

—

(3001604) Monocytes [#/volume] in Blood

3250

18104

5.33

307.65

11.8

6.2

0.62

e9/l

0.09

2952

15296

(3023520) Reticulocytes [#/volume] in Blood

1257

3987

4.15

307.65

4.0

2.5

69.69

68.91

e9/l

0.27

1014

2933

(3022096) Basophils/Leukocytes in Blood

3119

16751

4.98

307.65

12.5

6.6

0.68

0.67

0.76

3055

15619

(3045142) Bone marrow Pathology biopsy report

884

411

27.36

307.65

1.6

1.3

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

3325

20348

4.85

307.65

27.7

9.5

3.57

4.26

e9/l

63.46

3083

17498

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

419

179

26.04

307.65

3.1

2.3

231.00

223.91

e6/l

0.15

359

152

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

799

185

53.78

307.65

1.3

1.2

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

677

548

14.68

307.65

2.6

2.7

8243.98

993.53

u/ml

1.06

(3024561) Albumin [Mass/volume] in Serum or Plasma

2951

17234

3.75

302.15

9.3

5.3

33.89

35.00

g/l

20.54

2867

16126

(3002179) Metamyelocytes/Leukocytes in Blood

1052

3278

4.00

293.10

6.8

4.2

0.79

0.71

0.77

741

1009

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

456

718

7.04

281.40

2.3

1.6

—

(3021440) Promyelocytes/Leukocytes in Blood

1023

3307

3.82

267.95

7.0

4.4

0.20

0.11

3.44

716

925

(3032352) Blasts [#/volume] in Cerebral spinal fluid

147

61.02

264.28

1.8

2.5

—

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

306

323

10.18

262.97

1.6

1.5

—

(3000060) B lymphocytes [#/volume] in Blood

167

30.01

251.99

2.5

1.8

0.47

0.22

e9/l

0.30

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1349

5463

3.22

244.52

7.2

6.2

1.04

mmol/l

0.30

1307

5078

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

456

848

5.94

237.41

1.9

1.4

—

(3023368) Bacteria identified in Blood by Culture

2169

11634

2.90

233.67

8.3

4.5

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

355

555

6.92

219.39

1.3

1.2

277.41

262.93

u/ml

0.29

213

323

(3048929) Epstein Barr virus Ab [Presence] in Serum

429

810

5.82

219.34

1.3

1.2

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

407

731

6.09

219.29

1.8

1.4

—

(3020630) Protein [Mass/volume] in Serum or Plasma

1021

3711

3.36

218.53

2.9

2.7

64.15

66.08

g/l

9.42

977

3377

(3025159) Blasts/Leukocytes in Blood

950

3319

3.45

216.54

7.3

4.5

0.18

0.13

0.50

637

869

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

2980

19549

3.09

209.97

13.7

7.7

1.22

1.21

mmol/l

10.10

2612

16848

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

145

25.91

208.18

1.4

1.2

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1497

7067

2.79

198.17

3.0

2.0

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

2754

17617

2.83

197.62

11.9

7.0

1.22

1.21

mmol/l

6.82

2677

16226

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

344

616

6.02

185.28

1.9

1.4

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

319

533

6.42

184.30

2.0

1.5

—

(40760892) CBC W Ordered Manual Differential panel - Blood

1500

7351

2.67

181.20

10.3

4.9

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

96.25

180.44

1.1

1.0

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

372

735

5.48

180.21

1.9

1.4

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

264

373

7.51

178.47

2.4

1.7

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

273

402

7.22

177.79

5.3

4.0

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

273

402

7.22

177.79

2.4

1.7

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

548

1499

4.08

177.43

2.4

2.7

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

308

516

6.39

177.36

1.9

1.5

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

249

333

7.91

176.59

1.3

1.2

—

(3018418) pH of Serum or Plasma

2051

11773

2.53

176.55

8.5

4.4

7.41

7.40

14.17

1556

8583

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

205

217

9.91

175.07

1.2

85.20

83.41

0.15

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

143

16.82

170.35

3.8

2.6

1.12

2.32

ratio

3.66

137

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

814

2965

3.19

169.60

2.2

1.7

—

(3017354) Segmented neutrophils/Leukocytes in Blood

279

443

6.70

169.20

5.1

3.6

53.90

58.17

1.99

262

370

(3015377) Calcium [Moles/volume] in Serum or Plasma

2182

13063

2.48

168.89

7.6

3.6

2.35

mmol/l

0.57

2080

11778

(3007164) IgA [Mass/volume] in Serum or Plasma

1320

6256

2.66

168.40

2.7

1.5

1.99

2.67

g/l

19.64

1085

3661

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

183

178

10.73

165.96

4.3

3.2

1.57

1.25

0.94

183

178

(3037756) Immunofixation for Serum or Plasma

403

936

4.68

161.10

1.4

1.7

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1166

5308

2.69

160.07

2.6

1.8

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

215

285

7.92

153.42

2.6

2.3

21.06

31.46

iu/ml

0.60

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1102

4970

2.68

153.21

2.7

1.9

—

(44790047) Parainfluenza type 1 nucleic acid detection

277

484

6.08

152.54

1.7

1.4

—

(44790048) Parainfluenza type 2 nucleic acid detection

277

484

6.08

152.54

1.7

1.4

—

(44790049) Parainfluenza type 3 nucleic acid detection

277

484

6.08

152.54

1.7

1.4

—

(44806118) Parainfluenza type 4 nucleic acid detection

277

484

6.08

152.54

1.7

1.4

—

(40758292) HTLV I+II Ab panel - Serum

110

20.17

143.12

1.5

1.3

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

2506

16766

2.34

139.75

4.8

2.9

—

estimate

—

(3000012) Reticulocyte production index

314

668

5.02

139.11

2.8

2.1

0.97

0.90

0.91

254

457

(21494434) Karyotype in Bone marrow

231

383

6.34

133.93

1.2

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1449

7832

2.34

132.88

5.1

3.1

2.48

2.46

mmol/l

5.77

1399

7009

(3044640) Blood type and Crossmatch panel - Blood

1955

11996

2.24

131.64

4.7

2.6

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

357

887

4.32

130.28

1.3

1.2

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

134

121

11.43

127.61

2.0

1.9

4295.89

28145.35

u/ml

0.43

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

363

934

4.18

126.37

1.5

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

543

1839

3.26

125.41

2.6

1.9

2.75

2.61

ug/l

0.06

506

1625

(3021589) Normoblasts [#/volume] in Blood

2330

15588

2.19

123.29

23.1

12.5

0.01

0.00

e9/l

0.73

1978

12653

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

535

1823

3.24

122.17

2.6

2.5

4.01

4.20

g/l

5.93

510

1658

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

535

1824

3.23

122.05

2.6

2.5

7.17

7.42

g/l

2.42

509

1656

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

533

1821

3.22

121.13

2.6

2.5

3.64

3.76

g/l

0.44

509

1656

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

485

1568

3.38

120.60

2.7

2.5

1.33

1.02

g/l

0.78

417

1336

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

3291

25661

2.63

117.60

7.8

4.5

16.78

13.44

mm/h

20.65

3195

23852

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

200

331

6.31

116.01

2.6

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

200

331

6.31

116.01

2.6

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

200

331

6.31

116.01

2.6

1.6

—

(3032080) INR in Blood by Coagulation assay

2623

18676

2.19

114.56

17.2

18.3

1.26

1.32

inr

8.20

2217

15764

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

472

1548

3.32

114.46

2.8

3.6

38.19

63.87

mg/l

1.52

398

1315

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

499

1696

3.22

114.08

2.7

2.5

3.10

2.91

g/l

3.21

474

1531

(3034860) Kappa light chains.free [Mass/volume] in Serum

472

1551

3.32

114.08

2.8

3.6

57.36

56.37

mg/l

0.05

401

1315

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

3426

27394

2.80

113.41

22.5

8.7

84.54

81.24

u/l

3.42

3371

25979

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

306

762

4.27

110.98

2.0

1.4

7224.55

753.34

e6/l

0.48

262

595

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

331

877

4.03

110.38

1.9

1.3

698.56

564.82

mg/l

2.57

322

826

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

435

1397

3.37

108.92

2.8

3.4

4.28

3.04

ratio

0.59

251

820

(3042936) Bacteria identified in Isolate by Culture

1087

5601

2.29

107.61

2.1

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

128

138

9.55

107.53

1.3

1.4

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

418

1322

3.42

107.19

2.7

2.4

0.07

0.03

g/l

0.61

386

1178

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

299

755

4.20

106.37

1.9

1.4

39.36

25.35

e6/l

0.29

244

557

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

466

1587

3.19

105.86

2.7

2.5

9.51

10.33

g/l

2.83

438

1405

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1175

6310

2.22

104.78

3.2

2.1

29.50

29.84

1.05

1147

6139

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1532

9196

2.08

101.79

4.4

2.6

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

395

1276

3.33

97.63

2.7

2.4

0.00

g/l

0.44

357

1109

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

290

775

3.96

95.30

1.8

1.3

3.68

3.83

mmol/l

1.21

276

724

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

164

271

6.27

95.15

2.1

1.4

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

16.91

93.62

1.5

1.2

876330.00

3788.33

u/ml

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

118

137

8.85

93.61

3.0

2.1

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

151

237

6.58

92.13

2.2

1.5

—

(3033658) Prothrombin time (PT) actual/Normal

1533

9462

2.01

92.04

6.2

4.4

85.13

85.35

0.14

1505

9285

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

116

135

8.82

91.85

3.0

2.1

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

116

135

8.82

91.85

3.0

2.1

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

368

1181

3.33

91.77

2.8

2.5

0.00

g/l

-0.00

357

1107

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

532

2130

2.73

89.48

2.1

1.7

1.55

g/l

0.03

451

1844

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

178

339

5.45

88.99

2.2

1.5

—

(3042631) Mycobacterium sp identified in Specimen

238

580

4.30

88.51

2.1

2.8

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

151

247

6.31

88.47

2.2

1.5

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

222

513

4.52

88.39

1.1

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

235

568

4.33

88.34

1.3

120.17

215.70

miu/ml

2.42

214

(40768804) Tissue Pathology biopsy report

2022

13908

1.92

86.61

2.7

2.3

—

(3035933) Granulocytes/Leukocytes in Blood

268

728

3.87

85.92

5.9

3.2

56.41

58.24

1.11

268

728

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

341

1090

3.33

85.43

3.4

2.4

3.74

3.57

g/l

1.05

332

1041

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

382

1319

3.10

84.10

1.6

1.3

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

129

189

7.02

83.94

3.0

1.9

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

129

189

7.02

83.94

3.0

1.9

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

129

189

7.02

83.94

3.0

1.9

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

129

189

7.02

83.94

3.0

1.9

—

(3003694) ABO and Rh group [Type] in Blood

1470

9325

1.91

78.34

1.6

1.3

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

2828

22120

1.96

77.99

8.7

5.4

6.69

6.84

mmol/l

4.15

2772

21129

(3008536) Aspergillus sp Ab [Presence] in Serum

11.00

75.71

2.3

1.9

—

(3000093) Morphology [Interpretation] in Blood Narrative

180

400

4.67

75.15

1.2

1.1

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

821

4295

2.15

74.82

4.7

2.9

8.59

9.29

umol/l

0.38

747

3818

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1054

6062

2.00

74.25

2.6

2.8

23.75

22.10

2.31

1000

5647

(3019832) Treponema pallidum Ab [Presence] in Serum

393

1493

2.81

72.49

1.5

1.6

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1105

6514

1.96

72.18

2.6

2.7

2.15

2.26

g/l

8.03

1041

6025

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

16.91

72.07

1.4

2.0

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

118

188

6.44

70.90

1.2

—

(3022948) Iron [Moles/volume] in Serum or Plasma

1151

6916

1.93

70.82

2.6

2.8

12.70

12.39

umol/l

0.57

1094

6450

(40758558) Short blood count panel - Blood

1622

10880

1.83

70.53

17.8

6.4

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

218

588

3.86

70.43

5.7

6.4

11.47

12.31

mg/l

2.03

203

552

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

808

4341

2.08

67.96

2.5

4.3

9.71

19.32

ug/l

1.49

574

3614

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

123

214

5.90

67.65

1.7

1.6

—

(3017732) Neutrophils [#/volume] in Blood

819

4448

2.06

66.77

4.5

3.3

4.99

4.86

e9/l

0.10

718

3768

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

122

214

5.85

66.53

1.7

1.6

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

15.08

65.67

1.2

1.5

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1846

13062

1.77

65.55

3.9

3.3

1844.94

1583.04

ng/l

1.68

1695

11434

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

272

907

3.15

63.16

2.0

1.9

12.20

12.27

mg/l

0.04

261

833

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

196

535

3.80

62.20

1.1

1.0

—

(36304419) Bacteria [Presence] in Urine

1529

10434

1.76

60.07

4.0

3.5

0.20

326.73

estimate

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

311

1157

2.83

59.36

1.8

—

(3030467) Casts [#/volume] in Urine by Automated count

1600

11087

1.74

59.35

4.1

3.5

0.48

0.45

e6/l

0.13

1227

8295

(3016018) Differential panel - Cerebral spinal fluid

157

379

4.27

58.95

1.8

1.4

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

15.04

58.81

1.7

2.5

1.51

1.27

mg/l

0.14

(3028433) Virus identified in Specimen by Culture

105

7.85

58.68

1.3

1.2

—

(3002582) Erythrocytes [#/volume] in Urine

1792

12849

1.72

58.48

4.2

3.7

31.19

79.89

e6/l

5.78

1421

9968

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1508

10345

1.74

57.49

2.4

3.17

2.87

mg/l

3.86

1330

8914

(3031040) Bacteria [#/volume] in Urine by Automated count

2862

23419

1.79

57.08

6.0

5.2

1265.69

1546.79

e6/l

0.12

370

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

463

2128

2.33

56.82

1.7

1.5

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

156

388

4.14

56.30

3.4

3.0

—

(3000494) Fungus identified in Specimen by Culture

774

4358

1.96

55.94

1.7

1.5

—

(3018095) Leukocytes [#/volume] in Urine

1919

14128

1.69

55.91

5.0

4.3

132.52

108.89

e6/l

0.28

1460

10287

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

114

230

5.07

53.34

3.0

1.7

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

354

1500

2.49

51.91

2.0

1.8

42.54

38.58

u/l

2.51

315

1296

(3000991) Gas panel - Venous blood

675

3715

1.98

51.74

8.8

8.9

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

8.68

51.21

1.8

1.3

—

(3020779) Urea [Moles/volume] in Serum or Plasma

701

4010

1.91

47.58

7.8

7.4

10.41

10.65

mmol/l

0.36

688

3831

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

343

1498

2.41

46.96

3.4

3.0

0.36

0.34

iu/ml

0.56

210

832

(3014148) Varicella zoster virus Ab [Titer] in Serum

128

316

4.15

46.65

1.1

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

8.16

46.54

1.7

1.4

—

(3009343) pH of Capillary blood

529

2769

2.05

46.32

4.7

3.9

7.43

7.42

8.37

461

2311

(3002032) Base excess in Venous blood by calculation

727

4246

1.87

46.14

5.8

3.8

1.91

1.87

mmol/l

0.10

646

3697

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

540

2854

2.03

46.02

4.7

3.9

5.02

5.14

kpa

3.23

527

2729

(3021447) Carbon dioxide [Partial pressure] in Venous blood

741

4359

1.86

45.95

5.8

3.8

5.70

5.83

kpa

3.32

731

4242

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

134

346

3.97

45.95

1.4

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

7.96

45.56

1.2

1.5

—

(3012544) pH of Venous blood

746

4418

1.85

45.21

5.8

3.8

7.39

7.38

3.93

452

2559

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

568

3147

1.94

42.04

10.4

4.1

1.23

1.22

mmol/l

1.82

549

2751

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

7.87

40.84

1.4

1.1

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

6.87

40.69

1.6

1.3

—

(3000850) Epithelial cells [#/volume] in Urine

1283

9046

1.62

40.51

3.3

2.8

4.18

4.83

e6/l

1.28

1199

8253

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

464

2438

2.02

39.89

4.6

3.8

2.30

1.89

mmol/l

1.83

384

1782

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

499

2696

1.97

39.62

2.1

1.7

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1971

15413

1.55

39.37

3.6

3.1

371.76

150.22

ug/l

23.33

1850

14191

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1585

11826

1.57

38.91

3.1

2.7

56.33

67.51

u/l

0.95

1482

10948

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

7.36

38.56

1.0

1.1

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

260

1100

2.46

38.02

2.0

1.3

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

330

1551

2.23

37.88

2.1

3.5

262.40

3563.11

u/ml

1.16

267

1347

(3036481) Cortisol [Moles/volume] in Serum or Plasma

578

3328

1.86

37.75

2.2

2.4

381.21

378.45

nmol/l

0.12

555

3066

(3026782) Osmolality of Urine

1121

7755

1.62

37.72

3.4

3.1

527.02

536.37

mosm/kgh2o

0.87

1030

6816

(3025941) Bacteria identified in Stool by Culture

346

1669

2.18

37.22

1.4

1.3

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

958

6412

1.65

36.64

3.6

3.4

1.72

1.99

e6/l

0.51

492

3265

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1021

6946

1.63

36.58

3.5

3.2

1.01

1.11

e6/l

0.37

557

3811

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1121

7835

1.60

35.81

4.5

4.3

319.83

517.09

ng/l

0.50

975

6656

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

219

879

2.58

35.77

1.2

1.3

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

644

3895

1.78

35.62

8.2

7.6

1.50

1.34

mmol/l

2.04

634

3820

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

232

4.17

35.16

3.0

1.7

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1097

7660

1.60

35.04

2.2

1.8

1.98

1.46

mg/l

2.15

905

6053

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

160

4.89

34.86

3.4

6.1

36.80

56.76

u/ml

—

(3022313) Gas panel - Capillary blood

378

1936

2.05

34.68

5.1

4.1

—

(3037467) Urinalysis macro (dipstick) panel - Urine

2809

24086

1.56

34.65

5.9

4.9

2.01

2.83

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

327

1603

2.13

33.68

3.2

2.0

—

(3009871) Measles virus Ab [Titer] in Serum

6.05

33.24

1.9

1.5

3380.00

3632.00

titre

0.08

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

632

3885

1.75

32.82

2.3

2.2

0.19

0.20

g/l

5.46

589

3615

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

101

5.81

31.91

1.0

1.1

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

235

1036

2.35

31.30

1.5

1.23

10.55

iu/ml

0.78

204

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

5.84

30.98

1.4

1.2

20.78

27.27

0.25

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1856

14811

1.47

30.64

5.0

4.2

37.67

89.66

ng/l

1.10

1593

11452

(3002256) Pathology report gross observation

757

4970

1.65

30.53

1.4

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1970

15918

1.47

30.43

2.7

2.5

78.07

78.75

nmol/l

0.48

1847

14134

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

159

4.59

30.33

1.5

1.2

65.60

65.00

0.02

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

250

1151

2.25

30.06

6.8

3.4

1.57

1.69

mg/l

1.35

234

1033

(3024139) IgG subclass 3 [Mass/volume] in Serum

112

343

3.33

29.87

1.5

1.4

0.32

0.41

g/l

2.09

250

(3027135) IgG subclass 1 [Mass/volume] in Serum

112

343

3.33

29.87

1.5

1.4

5.94

6.86

g/l

1.26

250

(3028192) IgG subclass 2 [Mass/volume] in Serum

112

343

3.33

29.87

1.5

1.4

2.10

3.02

g/l

6.08

249

(3025468) Yersinia sp identified in Specimen by Organism specific culture

136

469

2.97

29.70

2.6

1.4

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

135

464

2.98

29.66

1.4

347.73

328.86

u/l

0.13

124

440

(3026008) Bacteria identified in Urine by Culture

1521

11724

1.48

29.63

3.9

3.5

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

154

569

2.78

29.63

1.6

0.48

0.88

g/l

6.59

113

448

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

136

471

2.95

29.48

2.6

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

136

473

2.94

29.25

2.6

1.4

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

151

557

2.78

29.14

1.2

1.1

—

(3003434) Protein [Mass/volume] in Pleural fluid

173

686

2.59

28.96

1.7

1.5

31.61

31.69

g/l

0.03

165

618

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

166

646

2.64

28.87

1.1

1.2

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

115

369

3.18

28.43

1.4

2.1

1574.68

3583.14

u/l

0.54

144

(3007853) Bacteria identified in Skin by Aerobe culture

676

4389

1.65

28.28

1.9

1.8

—

(4062490) Immunoglobulin typing, IgG

109

341

3.26

28.10

1.6

1.4

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

7.47

27.99

1.2

1.1

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

194

4.03

27.38

2.2

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

194

4.03

27.38

2.2

1.4

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

136

492

2.83

27.24

2.6

1.4

—

(3036489) Thrombin time

272

1349

2.09

27.08

3.0

2.0

21.98

21.26

0.77

256

1235

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

135

489

2.82

26.98

2.6

1.4

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

292

1490

2.04

26.91

2.4

1.9

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

136

496

2.80

26.83

2.6

1.4

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

628

4065

1.65

26.43

6.0

3.7

—

(3023419) Bacteria identified in Sputum by Culture

149

576

2.65

26.27

1.8

2.7

—

(3023410) Appearance of Cerebral spinal fluid

106

341

3.17

26.12

2.4

1.5

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

291

1505

2.01

25.82

5.5

4.2

25.62

24.80

mmol/l

4.46

276

1379

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

215

993

2.23

25.64

3.6

2.4

224.20

203.23

2.12

205

947

(3019977) pH of Arterial blood

748

5115

1.57

24.93

9.6

7.7

7.43

7.42

2.96

422

2817

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

282

3.32

24.55

2.0

1.4

—

(3019225) pH of Specimen

587

3809

1.63

24.32

7.6

4.7

7.39

7.35

5.95

529

2720

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

195

888

2.26

24.06

1.5

1.6

—

(3003396) Base excess in Arterial blood by calculation

740

5090

1.56

23.93

9.4

7.6

1.16

0.97

mmol/l

0.62

604

4183

(40768806) Pleura Pathology biopsy report

133

512

2.65

23.67

1.6

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1473

11642

1.42

23.57

6.3

3.3

36.34

37.38

u/l

0.19

1408

10962

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

280

3.27

23.46

2.0

1.4

—

(3016502) Oxygen saturation in Arterial blood

678

4615

1.57

22.87

9.7

7.8

96.08

95.37

3.33

651

4457

(3027801) Oxygen [Partial pressure] in Arterial blood

737

5123

1.54

22.59

9.6

7.6

12.54

12.09

kpa

1.30

711

4927

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

737

5124

1.54

22.57

9.6

7.6

4.98

5.09

kpa

2.69

706

4925

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

148

4.10

22.01

1.2

1.1

1667.77

366.92

ng/l

1.02

(3001686) Cold agglutinin [Titer] in Serum or Plasma

5.59

21.77

1.7

1.3

39.88

144.25

titre

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

541

3549

1.61

21.25

2.5

38.19

52.86

u/l

0.53

462

2975

(3012441) Differential panel - Pleural fluid

129

522

2.52

20.77

1.7

1.5

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

283

1561

1.88

20.71

3.2

3.1

24.48

24.76

mmol/l

0.57

278

1540

(3024354) Oxygen [Partial pressure] in Venous blood

549

3637

1.59

20.66

5.5

3.2

4.68

4.49

kpa

1.10

538

3533

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

101

363

2.83

20.54

1.4

1.3

29.48

11.82

u/l

1.43

331

(3002173) Hemoglobin [Mass/volume] in Arterial blood

621

4248

1.55

20.28

10.8

8.4

112.42

120.82

g/l

19.85

604

4149

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

3511

32765

1.61

20.17

43.9

18.8

25.57

26.78

mg/l

1.53

3347

27615

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

197

973

2.08

19.82

1.7

1.5

0.22

0.24

g/l

1.87

179

928

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

201

1004

2.06

19.62

1.7

1.5

1.11

1.18

g/l

2.15

195

956

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

259

1413

1.89

19.60

2.8

3.8

99.13

82.03

u/ml

0.33

250

1361

(3035350) Ketones [Presence] in Urine by Test strip

2185

18809

1.36

19.37

4.7

4.2

2.70

3.20

estimate

0.06

549

4123

(40768797) Stomach Pathology biopsy report

715

5091

1.49

19.25

1.4

1.3

—

(3036782) Glucose [Moles/volume] in Pleural fluid

119

481

2.52

19.22

1.5

1.4

6.06

6.37

mmol/l

0.64

113

452

(3015736) pH of Urine

1784

14912

1.36

19.02

4.1

3.6

6.25

0.08

945

8189

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

292

2.95

18.79

1.4

1.2

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

254

1396

1.88

18.79

1.2

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

221

3.25

18.56

1.2

1.1

71.47

40.19

mg/l

2.29

177

(3021601) Nitrite [Presence] in Urine by Test strip

2157

18604

1.35

18.49

4.7

4.1

0.00

estimate

1.08

539

4009

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

2032

17379

1.35

18.37

3.0

2.5

—

(3023199) Leukocytes [#/volume] in Pleural fluid

135

596

2.31

17.97

1.6

1.5

1956.07

3516.49

e6/l

0.51

417

(3028308) Erythrocytes [#/volume] in Pleural fluid

124

533

2.37

17.56

1.5

1.4

22179.17

76103.73

e6/l

2.08

295

(3024471) HLA-A [Type]

4.42

17.51

1.0

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

215

3.20

17.35

1.2

1.0

430.32

297.47

mg/l

1.73

179

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

20.96

17.27

1.7

2.6

—

(3009261) Glucose [Presence] in Urine by Test strip

2181

18953

1.33

17.19

4.8

4.2

0.01

0.09

estimate

0.51

519

3819

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

13.27

16.92

1.2

1.1

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

165

817

2.06

16.52

1.5

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

165

817

2.06

16.52

1.5

1.3

—

(1616796) Gas panel - Central venous blood

185

957

1.98

16.41

4.0

4.2

—

(3037522) Nuclear Ab [Titer] in Serum

624

4455

1.48

16.34

1.4

1.3

687.48

490.86

titre

1.34

139

983

(3024932) HLA-DR beta [Type]

4.30

16.16

1.4

1.1

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

145

691

2.14

16.06

1.7

1.4

10.74

9.68

u/l

0.47

124

556

(3021960) Folate [Moles/volume] in Serum or Plasma

1421

11696

1.33

15.89

1.8

19.41

20.07

nmol/l

0.92

1241

9804

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

187

3.24

15.70

1.1

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

181

946

1.96

15.59

2.3

3.5

539.87

879.09

u/ml

0.24

163

867

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

17.24

15.59

1.6

1.2

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

168

3.37

15.57

1.3

1.6

—

(3010937) Rubella virus Ab [Presence] in Serum

22.11

15.52

1.0

1.1

—

(3026389) Candida sp identified in Specimen by Organism specific culture

103

437

2.39

15.06

1.3

1.4

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

569

4050

1.47

15.05

1.3

1.4

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2401

21361

1.31

14.97

4.2

3.4

61.94

55.54

u/l

1.90

2268

19761

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

5.78

14.91

12.5

3.2

44.56

40.02

umol/l

0.45

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

163

3.34

14.89

1.2

1.1

1.25

1.17

u/l

0.32

(21494890) Protein electrophoresis panel - 24 hour Urine

107

466

2.33

14.76

1.9

2.1

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

309

1939

1.64

14.36

4.1

3.5

25.12

25.17

mmol/l

0.11

303

1874

(40761536) Microorganisms panel - Urine sediment

417

2819

1.54

14.11

5.1

4.3

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

6.42

14.09

1.3

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

6.42

14.09

1.3

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

6.42

14.09

1.3

1.1

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

401

2691

1.55

14.03

10.8

6.7

24.75

24.48

mmol/l

0.66

380

2580

(3004119) Hemoglobin [Mass/volume] in Venous blood

401

2693

1.54

13.98

5.2

3.2

119.69

128.13

g/l

10.10

396

2610

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

267

2.73

13.92

1.1

—

(3047189) Immunofixation for 24 hour Urine

212

2.95

13.91

1.5

1.8

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

127

611

2.11

13.77

1.2

1.3

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

292

2.63

13.72

1.1

—

(3012501) Base excess in Blood by calculation

160

851

1.92

13.13

4.2

4.9

2.74

2.69

mmol/l

0.08

123

592

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

16.75

12.96

1.5

1.0

1.27

1.23

iu/ml

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

375

2524

1.54

12.92

14.0

10.1

15.13

15.90

6.55

357

2438

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

13.01

12.89

2.2

6.6

—

(3010375) cycloSPORINE [Mass/volume] in Blood

158

3.19

12.85

33.9

29.0

104.20

117.73

ug/l

0.87

133

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

200

2.93

12.85

1.2

1.0

—

(3035880) pH of Pleural fluid

267

2.65

12.84

1.4

7.41

7.40

0.05

181

(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method

+∞

12.50

1.0

0.0

—

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

2881

26555

1.31

12.35

48.8

23.3

14.53

13.80

108.74

2871

26184

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

442

3108

1.47

12.33

3.9

4.1

87.29

96.32

ng/l

1.17

371

2649

(21491868) Cryoglobulin [Mass/volume] in Serum

132

3.36

12.30

2.0

1.2

1.38

0.10

g/l

—

(3017704) Immunofixation for Urine

233

2.73

12.29

1.4

1.6

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1442

12210

1.28

12.19

2.3

159.77

214.24

u/l

2.63

1375

11528

(3042010) Triglyceride [Moles/volume] in Pleural fluid

3.98

12.17

1.2

4.11

2.01

mmol/l

0.58

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1200

14264

0.77

12.03

2.0

1.38

1.33

mmol/l

1.10

977

11794

(3045788) Cell count panel - Pleural fluid

104

489

2.16

12.01

1.5

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

368

2.34

11.96

1.2

1.1

—

(4027681) Cerebrospinal fluid IgG ratio and IgG index

161

3.07

11.83

1.3

1.2

0.53

0.51

ratio

0.29

(40768443) Skin Pathology biopsy report

264

1680

1.61

11.60

1.3

1.2

—

(40757373) Influenza virus identified in Isolate

3.91

11.53

1.6

1.4

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

5.02

11.46

1.9

1.2

73.16

107.70

ng/l

0.26

(3052851) Hemolysis interference index of Serum or Plasma

183

1066

1.75

11.24

3.9

3.6

2.56

1.82

index

0.78

539

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

4.45

11.18

1.2

1.4

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

172

2.93

11.17

1.1

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

145

792

1.86

11.02

1.2

1.3

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

241

2.60

11.01

1.1

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

5.74

11.00

1.0

1.1

—

(40765089) Chromosome analysis panel - Blood by G-banded

5.74

11.00

1.0

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

363

2.29

10.99

1.2

1.3

—

(3013862) HLA-DP [Type]

13.90

10.95

1.0

—

(3010838) Calcium [Moles/time] in 24 hour Urine

120

618

1.97

10.88

1.8

1.9

5.36

4.61

mmol/24h

1.26

105

535

(3029937) Albumin [Presence] in Urine by Test strip

1260

10606

1.28

10.86

5.1

4.3

0.01

0.00

estimate

0.44

494

3631

(3052592) Norovirus Ag [Presence] in Stool

4.11

10.86

1.7

1.4

—

(3001893) Eosinophils/Leukocytes in Pleural fluid

155

2.99

10.67

1.9

1.5

1.93

2.67

0.29

135

(3024891) Influenza virus A+B Ag [Presence] in Specimen

142

782

1.85

10.53

1.3

1.2

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

143

792

1.84

10.42

1.3

84.09

40.91

u/l

1.91

126

685

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

106

3.42

10.40

2.1

1.6

1.34

5.92

ug/l

1.09

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

281

1863

1.55

10.37

2.6

3.4

4.26

4.42

pmol/l

1.81

255

1635

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

174

2.84

10.36

1.1

—

(3020393) Adenovirus Ag [Presence] in Stool

8.19

10.30

1.7

1.2

—

(3005532) Lymphocytes/Leukocytes in Pleural fluid

181

2.78

10.21

1.9

1.5

69.02

67.54

0.11

150

(40760409) HLA-A [Type] by High resolution

13.13

10.14

1.0

—

(46236302) HLA-C [Type] by High resolution typing

13.13

10.14

1.0

—

(40763590) HLA-DQ beta [Type]

13.13

10.14

1.0

—

(40760410) HLA-B [Type] by High resolution

13.13

10.14

1.0

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

130

706

1.87

10.09

1.8

1.4

27.86

29.06

iu/l

0.14

105

595

(3022493) Free Hemoglobin [Mass/volume] in Plasma

167

2.84

9.94

1.5

5.0

66.72

62.45

mg/l

0.10

119

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

479

3553

1.40

9.91

3.3

3.1

268.91

215.51

ng/l

1.47

445

3279

(3019309) Folate [Moles/volume] in Red Blood Cells

879

7143

1.30

9.84

1.8

1204.86

1163.97

nmol/l

0.62

700

5362

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

3.63

9.80

1.1

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

3.99

9.76

1.6

1.1

—

(3023420) DNA double strand Ab [Units/volume] in Serum

213

1345

1.62

9.69

1.7

6.56

6.32

iu/ml

0.05

311

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

123

3.11

9.47

1.1

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

5.15

9.35

1.2

1.1

—

(3026250) Tacrolimus [Mass/volume] in Blood

140

2.95

9.33

35.4

35.7

6.83

7.24

ug/l

0.59

123

(3024316) Viscosity of Plasma

9.51

9.25

3.1

1.6

1.72

1.50

mpas

—

(3047181) Lactate [Moles/volume] in Blood

200

1264

1.61

9.09

10.8

5.9

1.31

1.33

mmol/l

0.09

173

1123

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

136

775

1.78

9.07

1.3

1.2

1.26

7.04

u/ml

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

4.42

9.07

1.2

1.3

24.66

18.42

u/l

0.40

(3044889) 12 lead EKG panel

2644

24473

1.24

8.99

5.6

4.6

0.33

1554.51

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

7.44

8.91

2.0

3.1

35.85

37.22

0.07

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

7.44

8.91

4.0

6.3

10.20

8.33

0.42

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

3.47

8.91

1.6

1.1

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

4.33

8.86

2.0

2.3

111.16

113.45

ng/l

0.03

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

130

739

1.78

8.76

1.2

400.63

357.54

titre

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

203

2.53

8.70

1.6

1.2

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

284

1960

1.48

8.69

10.1

5.1

1.55

1.60

0.48

264

1856

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

104

3.19

8.62

1.1

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

295

2056

1.47

8.59

1.3

82.12

60.52

au/ml

0.56

146

(3022145) Colonoscopy Study observation

540

4174

1.34

8.57

1.4

—

(3037121) Protein [Mass/volume] in Urine

207

1339

1.58

8.55

3.0

3.2

683.29

411.43

mg/l

0.58

104

600

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

158

957

1.68

8.50

1.4

1.2

42.54

35.20

u/ml

0.18

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

3.81

8.50

1.3

1.2

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

3.28

8.47

1.2

1.37

1.60

mmol/l

0.73

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

150

898

1.70

8.43

1.4

1.2

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

3.89

8.41

1.3

2.1

2.40

147.14

pmol/l

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

151

907

1.69

8.39

1.4

1.2

—

(40763629) HC gene rearrangements [Presence] in Bone marrow by Molecular genetics method

+∞

8.33

1.0

0.0

—

(42529406) Shigella sp [Presence] in Stool by Culture

151

912

1.68

8.22

1.4

1.2

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

1039

8786

1.25

8.15

4.4

4.0

0.00

0.14

—

109

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

150

909

1.68

8.07

1.4

1.2

1.94

3.43

u/ml

1.41

(3045424) Erythrocytes [Presence] in Urine

268

1863

1.47

7.92

2.4

2.2

0.02

0.47

estimate

0.50

553

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

315

2259

1.43

7.89

2.5

2.4

27.05

20.73

au/ml

0.32

182

(3006184) Hemoglobin [Mass/volume] in Capillary blood

165

1033

1.62

7.83

3.0

2.3

117.98

128.36

g/l

5.83

123

807

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

10.80

7.78

1.8

1.2

0.86

3.32

mg/l

—

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

10.80

7.78

1.8

1.2

0.38

4.38

mg/l

—

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

10.80

7.78

1.8

1.2

0.92

6.15

mg/l

—

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

10.80

7.78

1.8

1.2

1.18

2.31

mg/l

—

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

10.80

7.78

1.8

1.2

0.19

3.42

mg/l

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

10.80

7.78

1.2

—

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

10.80

7.78

1.8

1.2

0.09

1.59

mg/l

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

149

911

1.66

7.77

1.4

1.2

2.77

5.67

u/ml

1.25

132

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

3.65

7.73

1.1

433.33

886.67

titre

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1911

17283

1.20

7.54

2.3

2.2

92.21

94.35

pmol/l

1.19

1123

9202

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

10.03

7.52

1.8

1.2

1.65

2.76

mg/l

—

(3023183) Ammonium ion [Moles/volume] in Plasma

149

919

1.65

7.52

2.4

2.6

33.68

34.87

umol/l

0.21

141

813

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

3046

31933

0.80

7.50

5.0

5.4

1.35

1.43

mmol/l

18.14

2753

29227

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

200

2.42

7.49

1.7

1.2

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

323

2.09

7.40

1.1

—

2.04

—

(3018405) Lactate [Moles/volume] in Arterial blood

210

1410

1.52

7.37

4.8

3.7

1.62

1.40

mmol/l

1.05

203

1388

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

149

2.63

7.28

1.5

1.3

1.36

412.91

ug/l

1.35

(3032057) Clostridioides difficile [Presence] in Stool

3.23

7.24

1.9

2.0

—

(3023383) Lactate [Moles/volume] in Pleural fluid

139

2.68

7.14

1.4

3.33

3.20

mmol/l

0.09

126

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

128

2.75

7.11

1.1

1.0

1106.77

1608.09

miu/ml

1.90

128

(3046861) Legionella sp Ag [Presence] in Urine

6.56

7.10

1.1

1.0

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

12.03

7.07

1.2

1.3

—

(3020951) Lymphocytes/Leukocytes in Cerebral spinal fluid

4.06

7.07

1.2

68.36

52.44

0.67

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

461

1.88

7.07

3.2

3.7

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

124

2.76

6.95

1.3

1.2

—

(40768441) Liver Pathology biopsy report

246

2.21

6.90

1.1

1.4

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

13.78

6.88

1.0

—

(3005322) IgE [Units/volume] in Serum or Plasma

275

1976

1.42

6.84

1.4

1.3

475.29

248.67

u/ml

0.92

237

1826

(3007930) Methemoglobin/Hemoglobin.total in Blood

254

1799

1.44

6.84

11.2

5.3

0.88

0.86

0.35

235

1702

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

3078

32162

0.81

6.81

5.1

5.5

4.40

4.46

mmol/l

2.86

2814

29653

(3003327) Ova and parasites identified in Stool by Light microscopy

158

1015

1.58

6.79

1.8

1.7

—

(3044927) Protein electrophoresis panel - Urine

442

1.87

6.65

1.1

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

7.80

6.60

1.4

1.6

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

12.25

6.57

1.1

1.0

—

(3028029) Mesothelial cells/Leukocytes in Pleural fluid

3.18

6.56

2.0

1.5

4.85

6.85

0.53

(3039162) Centromere protein B Ab [Units/volume] in Serum

395

1.92

6.53

1.3

1.2

61.35

57.63

u/ml

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

113

675

1.69

6.49

1.3

1.2

36.29

47.49

u/ml

0.37

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

399

3073

1.33

6.46

3.8

2.8

59.54

62.44

ml/min/173m2

0.76

173

1360

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

3020

31578

0.82

6.45

6.6

7.2

40.02

40.14

mmol/mol

0.26

2770

29257

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

3304

31694

1.25

6.37

38.4

18.8

76.01

75.67

ml/min/173m2

0.43

3177

29599

(3018572) Chloride [Moles/volume] in Blood

139

886

1.59

6.20

14.1

6.9

105.33

105.10

mmol/l

0.17

122

793

(3039000) Anion gap in Blood by calculation

139

886

1.59

6.20

14.1

6.8

10.65

11.37

mmol/l

1.88

122

793

(3036603) Volume of Urine

278

2.07

6.17

1.6

1.7

2076.35

1864.02

1.06

271

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

6.27

6.15

1.0

1.1

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

169

2.38

6.12

1.4

1.3

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

134

2.55

6.02

1.1

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

184

1257

1.49

6.00

1.4

1.3

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

2.93

5.99

2.0

2.3

3.15

403.29

ug/l

0.67

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

3155

32776

0.82

5.81

5.7

6.3

2.56

2.57

mmol/l

0.06

2850

30090

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

11.14

5.79

3.1

2.8

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

3518

34074

1.28

5.74

44.1

22.9

139.30

139.64

mmol/l

12.63

3486

33417

(3013945) Hepatitis B virus e Ab [Presence] in Serum

6.86

5.73

1.4

—

(3051611) Lipemic interference index of Serum or Plasma

371

1.88

5.69

4.1

3.6

15.05

11.34

index

1.91

202

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

458

1.78

5.69

1.1

27.85

23.05

au/ml

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

227

2.13

5.66

2.9

4.0

—

(3043410) Blood group antigens tested for on Red Blood Cells

106

2.65

5.40

2.7

1.9

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

2.75

5.36

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

2.75

5.36

1.1

1.0

—

(3020876) Protein [Mass/time] in 24 hour Urine

542

1.69

5.35

2.2

2.4

0.89

1.30

g/24h

0.93

319

(3003181) Sodium [Moles/volume] in Urine

125

807

1.57

5.33

1.5

1.4

57.73

61.76

mmol/l

0.59

101

654

(3023103) Potassium [Moles/volume] in Serum or Plasma

3518

34124

1.27

5.31

44.8

23.1

4.00

mmol/l

0.03

3483

33412

(3008295) Osmolality of Serum or Plasma

446

1.76

5.30

1.3

1.4

273.97

275.85

mosm/kgh2o

0.38

330

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

9.11

5.28

1.0

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

428

3426

1.28

5.22

2.7

2.6

0.46

0.52

e6/l

0.25

418

3300

(3028468) Fragments [Presence] in Blood by Light microscopy

+∞

5.21

1.0

0.0

—

(3014051) Protein [Presence] in Urine by Test strip

1093

9645

1.18

5.16

3.4

3.2

0.15

0.05

0.59

285

(3024928) Oxygen saturation in Venous blood

160

1099

1.47

5.13

7.0

2.9

59.39

60.13

0.15

152

1066

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

258

1.99

5.07

1.7

1.5

0.21

0.28

nmol/l

1.03

187

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

130

2.40

4.88

5.9

2.6

4.72

4.87

kpa

0.28

130

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

130

2.40

4.88

5.9

2.6

10.01

9.94

kpa

0.05

130

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

473

1.71

4.87

1.2

3.26

3.81

u/ml

0.20

170

(44786800) Granulocytes/Leukocytes in Body fluid

3.28

4.74

1.4

1.3

20.73

17.26

0.14

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.41

4.74

1.1

—

(40757494) Bilirubin.total [Moles/volume] in Blood

206

2.05

4.57

2.1

2.3

14.14

25.07

umol/l

—

(3003740) Influenza virus B Ag [Presence] in Specimen

384

1.76

4.57

1.3

1.1

—

(40758358) Immune stain study

8.20

4.56

1.0

—

(3049717) Cytology report of Urine Cyto stain

236

1783

1.34

4.42

2.5

2.8

—

(3045414) Leukocytes [Presence] in Urine

446

3662

1.25

4.40

2.5

2.2

0.01

estimate

0.18

724

(3044242) Glucose [Moles/volume] in Arterial blood

266

1.89

4.35

2.1

2.0

8.73

8.30

mmol/l

0.29

266

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

170

2.13

4.34

2.0

1.5

39.62

39.91

g/l

0.10

170

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1518

13887

1.15

4.34

4.9

4.2

0.02

0.22

estimate

0.71

463

3313

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

3.96

4.29

1.0

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

386

1.72

4.22

1.3

1.1

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

462

1.66

4.22

1.2

4.26

5.89

u/ml

0.56

214

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

3.15

4.20

1.1

1.2

—

(4212803) Bone marrow aspirate examination

4.13

4.20

1.2

1.1

—

(3012516) Albumin [Mass/volume] in Urine

1210

13346

0.87

4.16

3.6

3.5

53.97

51.22

mg/l

0.16

786

8716

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

141

2.21

4.11

1.3

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

173

2341

0.73

4.08

2.0

2.1

3.55

3.49

ratio

0.28

132

1895

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

116

2.34

4.08

1.2

10.64

14.08

pmol/l

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

10.01

4.01

1.1

1.0

—

(1761868) Lipid panel - Serum or Plasma

980

10950

0.86

3.99

3.4

3.5

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

267

1.85

3.99

5.6

40.94

43.59

u/ml

0.05

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

2953

30617

0.86

3.95

4.4

4.6

1.33

1.29

mmol/l

1.70

2661

27696

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

184

2.02

3.93

6.4

6.9

13.82

123.29

ug/l

0.60

113

(3041096) Erythrocytes [Presence] in Urine by Automated

1076

9663

1.16

3.90

4.4

3.7

0.02

0.20

estimate

0.88

440

3139

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

3.79

3.89

1.0

1.2

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

164

1196

1.39

3.87

1.5

256.21

267.80

ug/g

0.29

102

742

(3031659) Enterovirus Ab [Titer] in Cerebral spinal fluid

7.29

3.85

1.0

1.1

—

(3017569) Oxygen content in Arterial blood

263

1.84

3.85

2.6

2.3

14.34

16.29

4.52

263

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

3.19

3.77

1.6

1.5

—

(3033086) Enterovirus Ab [Titer] in Serum

8.76

3.77

1.0

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

147

2.12

3.74

1.5

2.2

2699.12

5951.62

e6/l

0.26

103

(3020682) Albumin/Creatinine [Ratio] in Urine

1244

13610

0.87

3.70

4.3

4.2

11.45

9.38

mg/mmol

0.46

788

8632

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

7.79

3.55

1.4

1.2

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

7.79

3.55

1.1

1.0

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

202

1544

1.32

3.55

2.1

2.2

376.05

613.73

ug/l

0.63

190

1469

(3043722) Hyaline casts [#/area] in Urine sediment by Automated count

10.01

3.49

1.2

1.0

1.17

0.83

u/field

—

(3035637) Corticotropin [Mass/volume] in Plasma

466

1.58

3.40

1.3

1.6

22.98

29.60

ng/l

0.93

466

(4268621) Lupus anticoagulant assay

342

1.68

3.40

2.1

2.3

—

(3018333) Ribosomal P Ab [Presence] in Serum

246

1.80

3.35

1.2

—

(3040151) Glucose [Moles/volume] in Capillary blood

476

1.57

3.34

5.9

20.3

7.51

7.47

mmol/l

0.04

400

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2636

25238

1.13

3.34

4.4

4.3

15.06

14.99

pmol/l

0.72

2424

22858

(3027456) Digoxin [Moles/volume] in Serum or Plasma

136

988

1.39

3.34

3.1

3.3

0.88

0.81

nmol/l

0.52

101

793

(3047007) Chlamydophila sp Ab [Presence] in Serum

375

1.64

3.32

1.1

1.2

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

299

1.71

3.31

1.4

1.2

122.98

98.91

pmol/l

2.02

299

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

8.58

3.26

1.2

1.1

2.30

1.51

mg/l

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

377

1.63

3.26

1.1

—

3.39

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3513

34348

1.19

3.22

27.6

13.2

27.00

26.19

u/l

0.99

3475

33191

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

213

1.84

3.21

1.0

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

257

1.76

3.21

1.2

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

214

1.83

3.17

1.6

8.55

7.42

u/l

0.13

171

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

251

1.76

3.16

1.2

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

163

1231

1.34

3.15

1.4

1.2

5.24

1.00

u/ml

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

186

1.89

3.14

2.1

1.7

1.21

2.49

u/field

1.42

132

(3033099) Centromere Ab [Titer] in Serum

2.54

3.12

1.1

—

(3009508) Creatinine [Moles/volume] in Urine

1266

13721

0.89

3.11

3.6

3.5

6.88

7.42

mmol/l

4.96

1054

11477

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

166

1.94

3.08

1.2

—

(40768446) Kidney Pathology biopsy report

132

2.05

3.06

1.2

1.6

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

307

1.67

3.04

1.2

—

(3024869) Neuronal Ab [Presence] in Serum

2.51

3.04

1.1

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

430

3662

1.20

2.99

2.3

2.4

7.15

7.32

ug/l

0.04

367

3229

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

898

8097

1.14

2.99

1.7

1.8

15541020.68

25613671.17

pmol/l

0.27

740

6645

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

263

1.72

2.99

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

263

1.72

2.99

1.2

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

197

1.83

2.97

1.3

1.7

15.95

13.57

umol/l

0.09

131

(3007566) Smooth muscle Ab [Titer] in Serum

130

960

1.37

2.93

1.3

1.2

104.29

104.43

titre

0.00

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

101

2.18

2.92

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

266

1.70

2.88

1.2

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

274

1.69

2.87

1.2

1.1

—

(3050794) Legionella sp Ab [Presence] in Serum

3.16

2.84

1.1

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

3.58

2.78

1.0

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

3.58

2.78

1.0

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

126

1.99

2.65

1.2

2.0

20185.22

19764.53

e6/l

0.01

(3002621) Streptococcal DNAse B [Units/volume] in Serum

3.34

2.60

1.0

1.1

—

204.14

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.19

2.57

1.2

1.1

—

(4015189) Microbial culture of sputum

107

2.06

2.57

1.3

2.1

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.86

2.54

1.0

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

2.61

2.53

1.1

1.2

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

2.14

2.44

1.3

1.1

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.34

2.39

1.0

1.1

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

282

1.60

2.36

1.4

1.2

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

3.48

2.27

1.0

—

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

129

1648

0.78

2.16

1.8

3.31

3.45

mmol/l

0.59

1199

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

3.00

2.14

2.3

4.3

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

268

1.57

2.08

1.2

—

115.00

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

2.71

2.06

1.5

2.3

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

231

1931

1.21

2.04

1.4

—

(3035320) C reactive protein [Mass/volume] in Body fluid

286

1.54

2.02

3.0

2.9

31.66

31.92

mg/l

0.01

215

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

118

1.87

2.01

1.3

1.1

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

1.96

2.00

1.3

1.1

—

(4195642) Thrombophilia screening test

419

1.44

1.97

1.3

1.2

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

436

1.43

1.96

1.1

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

2.36

1.94

1.1

1.0

—

(1002224) Polysomnography panel

1207

0.76

1.91

1.1

—

(3039443) Prostate specific Ag panel - Serum or Plasma

664

0.67

1.90

1.6

1.7

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

932

0.72

1.90

1.4

1.7

6.07

4.69

mg/l

0.22

698

(3020564) Creatinine [Moles/volume] in Serum or Plasma

3537

34821

1.14

1.90

50.7

25.1

84.63

82.97

umol/l

1.52

3507

34377

(3004451) EKG impression Narrative

260

1.54

1.86

1.3

—

(3038515) Glucose [Moles/volume] in Venous blood

112

873

1.29

1.86

4.8

3.4

7.01

7.63

mmol/l

2.38

112

848

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

205

1.61

1.85

1.5

8.49

7.19

u/l

0.24

181

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

309

1.49

1.85

1.3

1.1

75.50

56.00

u/ml

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

229

1.58

1.84

1.0

1.1

0.13

10.43

nmol/l

—

(3025130) Human papilloma virus identified in Specimen

264

1.52

1.76

2.3

1.8

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

154

1.69

1.75

1.1

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

185

1.63

1.75

1.2

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.50

1.74

1.0

1.1

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

2.92

1.72

1.1

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

140

1.72

1.71

2.5

2.6

0.60

0.61

mmol/l

0.46

140

(21494755) Public health laboratory ask at order entry panel

140

1715

0.81

1.69

1.3

1.4

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

3.16

1.66

3.3

3.5

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

2.80

1.65

1.0

1.8

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

2.03

1.64

2.0

1.9

1.80

2.08

ug/l

—

(3004616) Nuclear Ab [Presence] in Serum

419

1.39

1.63

1.5

1.2

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

1.84

1.61

1.1

1.4

79.69

83.72

0.17

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

498

1.35

1.59

2.0

2.2

23.37

21.55

mg/l

0.15

172

(3016750) Collection duration of Urine

223

1.53

1.56

2.3

2.1

512.17

493.29

min

0.53

165

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

493

4468

1.12

1.53

12.7

7.6

—

(36660697) Celiac disease serology panel - Serum

287

2517

1.15

1.50

1.2

—

(4281824) Cell count and differential, peritoneal fluid

335

1.41

1.45

1.1

1.2

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

3.13

1.44

1.2

1.1

198.40

235.50

nmol/l

—

(40768793) Breast Pathology biopsy report

728

1.27

1.42

1.3

—

(3002619) Bacteria identified in Specimen by Culture

1.82

1.41

1.4

1.2

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

431

1.35

1.41

1.2

1.3

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

1.77

1.38

1.1

1.2

76.17

85.11

0.55

(44816559) Phosphatidylethanol [Mass/volume] in Blood

110

1347

0.81

1.38

1.6

0.30

0.33

mg/l

0.18

623

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

757

0.75

1.37

2.5

1.6

0.97

0.85

nmol/l

0.57

633

(3048689) Calprotectin [Mass/mass] in Stool

432

3914

1.12

1.37

2.3

196.74

154.18

ug/g

1.18

367

3113

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

2.20

1.37

1.8

2.2

16.90

18.25

umol/l

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

454

0.68

1.34

1.0

1.1

6.28

2.18

u/ml

0.44

268

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

144

1.60

1.31

2.9

1.9

38.30

56.97

ug/l

1.45

139

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

637

0.73

1.31

1.1

0.58

0.65

ratio

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

368

0.65

1.31

1.0

1.1

1.98

1.83

u/ml

—

168

(3017315) Amylase [Enzymatic activity/volume] in Urine

178

1.52

1.26

1.2

158.04

352.03

u/l

1.89

165

(3010726) Horse dander IgE Ab [Units/volume] in Serum

339

0.65

1.24

1.0

1.1

10.79

1.52

u/ml

—

192

(3044007) Cell count panel - Peritoneal fluid

131

1.61

1.23

1.7

1.9

—

(3003329) Lymphocytes/Leukocytes in Synovial fluid

348

1.35

1.20

1.4

1.5

34.66

27.90

0.58

208

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

705

0.76

1.19

1.2

1.47

1.51

g/l

0.66

705

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

230

2025

1.14

1.18

2.4

2.5

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

2.31

1.18

1.0

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

686

1.24

1.16

1.3

1.4

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

0.00

1.16

0.0

1.1

—

31.59

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

126

1.59

1.14

2.8

24.92

29.33

umol/l

1.06

(3022621) pH of Urine by Test strip

316

2847

1.12

1.14

2.8

2.9

6.01

6.05

0.31

219

2019

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

734

1.23

1.13

1.1

4.54

7.95

eliau/ml

—

(3026480) Teichoate Ab [Titer] in Serum

2.26

1.10

1.0

1.1

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

337

1.34

1.09

1.0

1.1

1.59

2.72

eliau/ml

1.25

116

(3003888) Timothy IgE Ab [Units/volume] in Serum

373

0.70

1.06

1.0

1.1

8.77

4.20

u/ml

—

198

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

2.12

1.05

1.0

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

195

1.44

1.04

1.1

19.18

11.66

iu/ml

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

1.69

1.01

1.1

1.0

0.10

3.36

u/ml

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

126

1469

0.85

1.00

1.1

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

311

3415

0.90

0.98

1.7

1.8

1.50

1.57

0.57

257

2923

(3041672) Baker's yeast Ab [Presence] in Serum

2.18

0.98

1.0

1.1

—

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

2.18

0.98

1.0

1.2

—

24.00

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

2.18

0.98

1.0

1.2

—

30.82

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

2.18

0.98

1.0

—

(3000330) Specific gravity of Urine by Test strip

228

2038

1.13

0.97

3.7

3.5

1.02

ratio

0.60

210

1859

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.00

0.97

0.0

1.0

—

(3034426) Prothrombin time (PT)

1.63

0.97

1.2

1.3

27.40

28.47

0.34

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

525

0.76

0.96

1.4

1.5

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

117

1.54

0.93

1.0

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

117

1.54

0.93

1.0

—

(3013637) Mi-2 Ab [Presence] in Serum

117

1.54

0.93

1.0

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

117

1.54

0.93

1.0

—

(3029396) Erythrocyte agglutination [Presence] in Blood

2.22

0.93

1.0

2.3

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

1.73

0.92

6.9

13.9

7.73

5.21

mmol/l

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

1.63

0.90

3.4

2.3

6.47

8.08

mmol/l

—

(1761482) Bacteria [#/volume] in Urine by Culture

115

987

1.17

0.89

4.8

4.3

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

182

0.60

0.89

1.2

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

361

3327

1.09

0.88

2.6

2.3

12.66

13.03

nmol/l

0.36

332

2942

(3001019) Free T4 and TSH panel - Serum or Plasma

924

0.83

0.88

1.6

1.7

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

2.00

0.87

1.0

1.2

—

(3014891) Appearance of Pleural fluid

1.72

0.86

1.3

1.5

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

1.82

0.85

1.6

1.5

—

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

255

2804

0.90

0.85

1.5

1.4

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

1.78

0.84

6.4

5.6

40.38

54.13

ug/min

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

497

1.23

0.83

1.6

1.5

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

0.00

0.79

0.0

1.2

—

354.25

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

133

1506

0.88

0.76

1.5

1.8

—

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

2.08

0.74

1.0

2.6

—

113.55

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

2.00

0.72

1.2

3.0

—

(3008898) HLA-B27 [Presence]

839

1.16

0.72

1.1

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

371

1.24

0.71

1.6

1.3

24644.48

126314.55

e6/l

1.98

248

(3027231) Wheat IgE Ab [Units/volume] in Serum

1.75

0.71

1.1

1.0

0.35

8.52

u/ml

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

498

0.80

0.69

3.9

5.1

313.15

347.34

umol/l

0.84

435

(3006442) Creatine [Moles/volume] in Serum or Plasma

239

1.30

0.69

1.6

1.7

93.16

88.83

umol/l

0.12

239

(3032868) Hemoglobin electrophoresis panel in Blood

1.85

0.68

1.2

1.5

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

1.56

0.68

7.7

7.0

9.81

10.35

0.46

(4146454) Self-monitoring of blood glucose

473

0.80

0.66

2.9

2.7

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

145

1.38

0.65

1.0

—

(37208534) Antinuclear antibody arbitrary concentration in serum

103

1.46

0.65

1.1

1.0

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

155

1.36

0.63

1.4

1.3

5.99

6.14

mmol/l

0.26

148

(3028707) Methadone [Presence] in Urine by Screen method

280

0.75

0.62

1.6

2.3

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

104

0.58

0.61

3.0

2.3

125.67

145.53

nmol/l

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.46

0.61

2.3

1.4

11.22

8.95

ug/l

0.44

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.60

0.0

2.0

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

116

1034

1.13

0.59

2.0

1.9

46.91

42.70

nmol/l

1.01

116

993

(3006571) Granulocytes/Leukocytes in Synovial fluid

454

1.19

0.59

1.5

63.30

60.72

0.20

278

(3051387) C reactive protein [Mass/volume] in Capillary blood

799

1.14

0.59

3.8

3.6

26.12

29.65

mg/l

0.63

563

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1206

12401

0.96

0.56

4.4

4.9

21.73

22.04

0.31

639

6537

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

286

0.77

0.56

1.6

1161.73

935.70

mu/l

0.46

241

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

320

1.22

0.55

2.5

2.0

1.73

1.56

u/field

0.09

169

(43055514) Macroprolactin [Presence] in Serum or Plasma

1.62

0.55

1.2

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

195

1796

1.09

0.55

1.2

126.70

131.72

u/ml

0.06

627

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

142

1.34

0.54

1.1

133.11

223.10

iu/ml

1.63

142

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

359

1.20

0.52

1.2

1.6

30.86

25.38

u/ml

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

0.61

0.52

2.0

1.5

47.52

50.06

ug/l

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

151

1650

0.91

0.51

1.5

1.8

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

129

1171

1.11

0.51

1.7

1.6

25.87

21.18

u/ml

0.19

211

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

247

0.77

0.50

1.0

1.1

0.61

0.32

u/ml

—

106

(3024263) Appearance of Synovial fluid

213

0.75

0.50

1.5

1.6

—

(3024731) MCV [Entitic mean volume] in Red Blood Cells

3538

35165

1.05

0.49

59.6

28.3

92.13

91.64

7.88

3513

34715

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

1.43

0.49

1.0

—

(3035941) MCH [Entitic mass]

3538

35166

1.05

0.49

59.5

28.3

30.53

30.46

1.29

3513

34716

(44806420) Estimation of glomerular filtration rate

301

0.80

0.48

2.3

2.5

—

(3026361) Erythrocytes [#/volume] in Blood

3538

35168

1.05

0.48

59.7

28.4

4.15

4.44

e12/l

148.28

3474

34230

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

493

1.16

0.48

1.1

1.67

1.55

g/l

1.43

443

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

3538

35169

1.05

0.48

60.7

29.0

37.51

40.05

140.30

3511

34705

(3004775) Volume in Urine collected for unspecified duration

317

1.20

0.48

2.5

2.3

807.45

636.79

1.06

206

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

143

0.70

0.47

1.5

1.6

—

(3010813) Leukocytes [#/volume] in Blood

3538

35171

1.05

0.47

59.7

28.4

6.75

6.86

e9/l

1.06

3477

34230

(3007461) Platelets [#/volume] in Blood

3537

35163

1.05

0.47

59.8

28.4

216.79

242.56

e9/l

76.64

3482

34357

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

1.47

0.47

1.2

1.1

—

(3000963) Hemoglobin [Mass/volume] in Blood

3538

35174

1.05

0.46

60.1

28.6

124.24

134.25

g/l

212.03

3514

34736

(4198724) Urine methamphetamine measurement

0.61

0.45

1.0

1.7

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

298

0.80

0.45

1.0

1.1

11.12

2.38

u/ml

—

158

(3027944) Amphetamines [Presence] in Urine

589

0.86

0.45

1.2

1.8

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

112

1.34

0.44

1.3

2.4

235.53

190.21

0.75

105

(3000764) Benzodiazepines [Presence] in Urine

596

0.87

0.42

1.3

1.9

—

(3020874) Milk IgE Ab [Units/volume] in Serum

113

1.33

0.42

1.1

3.23

1.29

u/ml

—

(3012898) Urea [Moles/volume] in Urine

1.56

0.42

1.0

1.2

107.40

148.27

mmol/l

—

(3036071) Salmonella sp Ab [Titer] in Serum

1.38

0.42

1.2

1.1

—

(3050129) First trimester maternal screen panel - Serum or Plasma

184

0.76

0.41

1.5

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

0.00

0.41

0.0

10.2

—

103.47

—

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

0.00

0.40

0.0

1.0

—

79.18

—

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

0.00

0.40

0.0

1.1

—

34.90

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

3063

30389

1.03

0.40

5.5

5.4

2.05

2.00

mu/l

1.03

2829

27693

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

474

1.14

0.40

1.0

1.1

—

(3014271) Vancomycin [Susceptibility]

214

1.22

0.39

2.5

3.0

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

0.00

0.39

0.0

1.1

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

0.00

0.39

0.0

1.1

—

0.89

—

(3028300) Cannabinoids [Presence] in Urine

600

0.88

0.38

1.4

1.8

—

(3016879) Cocaine [Presence] in Urine

557

0.88

0.37

1.3

1.9

—

(3021788) Differential panel - Synovial fluid

743

1.11

0.37

1.5

—

1.00

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.35

0.37

1.8

2.4

0.40

0.54

u/field

—

(3034092) Cytoplasmic Ig cells/cells in Blood

1.35

0.37

6.6

9.2

0.68

0.20

—

(3001729) Color of Synovial fluid

1.35

0.37

1.6

1.5

—

(3027008) Opiates [Presence] in Urine

597

0.89

0.35

1.3

1.9

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

218

2303

0.94

0.35

1.2

1.3

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.40

0.35

1.0

1.1

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

426

0.87

0.34

1.4

1.3

1.36

1.53

nmol/l

0.59

384

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

729

7098

1.03

0.34

1.3

2.78

1.69

u/ml

0.73

158

1803

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

166

0.78

0.33

1.0

1.1

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.28

0.32

1.0

1.1

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

209

0.81

0.32

1.7

1.4

1.28

1.21

nmol/l

—

148

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

221

1.18

0.30

1.9

1.8

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

314

0.86

0.29

1.0

729.86

708.60

ng/l

0.09

208

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

556

0.90

0.29

1.1

2.00

58.88

iu/ml

—

(40768800) Prostate Pathology biopsy report

101

1085

0.93

0.29

1.2

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

270

0.85

0.28

1.0

1.1

1.75

4.17

u/ml

—

129

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

173

0.81

0.28

1.1

—

(3019150) Specific gravity of Urine by Refractometry

847

8302

1.03

0.26

5.1

4.4

1.02

1.20

kg/l

0.50

623

5664

(4211845) Urine protein measurement

178

1.18

0.26

2.7

3.8

—

(4024509) Urine culture

187

1784

1.05

0.25

2.1

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

127

0.79

0.25

2.7

1.7

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

1.25

0.24

1.1

1.3

1.89

3.77

umol/l

3.63

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.25

0.24

7.6

7.4

4.98

5.35

kpa

0.89

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

595

5821

1.03

0.22

1.3

47.32

35.62

iu/ml

0.80

190

1754

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.22

0.22

1.0

1.2

2.14

1.85

umol/24h

—

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

1.22

0.22

1.0

—

(4038314) Semen analysis, post vasectomy

0.00

0.21

0.0

1.3

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

0.21

0.0

1.1

—

(37019676) Renin [Units/volume] in Plasma --supine

0.00

0.21

0.0

1.0

—

8.09

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.21

0.0

1.1

—

(3016031) Almond IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

2.55

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

0.21

0.0

1.2

—

7.81

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.3

—

1.78

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

0.05

—

(4034850) Laboratory test

102

1078

0.94

0.20

13.3

11.4

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

594

0.92

0.20

1.4

1.8

—

(3006462) Nitrate [Presence] in Urine

164

1.16

0.20

2.9

3.9

—

(3030313) Adrenal Ab [Titer] in Serum

0.00

0.20

0.0

1.0

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

0.00

0.20

0.0

1.4

—

495.41

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

0.00

0.20

0.0

1.1

—

0.07

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.22

0.20

1.0

116.57

42.77

iu/ml

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

313

0.89

0.20

1.0

45.53

42.97

ng/l

0.16

210

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.22

0.19

1.5

1.4

1.14

1.17

mmol/l

0.73

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

312

0.90

0.19

1.0

343.43

316.84

ng/l

0.25

213

(44813793) Dust mix specific IgE antibody measurement

196

0.87

0.18

1.1

1.0

—

(3042733) HLA Ab [Presence] in Serum

100

1.20

0.18

4.1

4.7

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

466

0.92

0.18

1.4

1.9

—

(3022689) Creatine [Moles/volume] in Urine

121

0.83

0.18

2.0

1.4

7.40

7.76

mmol/l

—

121

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.17

0.17

2.0

1.5

—

(3002079) Sodium [Moles/time] in 24 hour Urine

142

0.84

0.17

1.5

1.3

101.83

169.87

mmol/24h

2.36

142

(4094501) Cardiovascular stress test using bicycle ergometer

1008

0.95

0.17

1.2

1.1

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

0.71

0.16

1.2

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

245

0.90

0.15

1.2

1.3

4.85

1.80

u/ml

0.45

143

(3011985) Renin [Units/volume] in Plasma

526

1.07

0.15

1.3

1.4

39.71

77.47

mu/l

1.25

472

(3020191) Ethanol [Moles/volume] in Serum or Plasma

276

0.91

0.15

1.3

1.4

1.06

1.13

promille

0.09

218

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

159

1.13

0.15

1.4

2.1

99.09

109.43

umol/l

0.12

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

112

1.16

0.14

1.2

1.3

19.00

10.75

mm/h

0.93

112

(3032773) Endomysium IgG Ab [Titer] in Serum

267

1.09

0.13

1.1

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

957

0.96

0.12

2.6

2.3

172.34

105.53

ug/min

0.42

569

(1617658) Protocol used for examination of sentinel lymph nodes

220

0.91

0.12

1.0

1.1

—

(3000034) Microalbumin [Mass/volume] in Urine

347

1.07

0.11

3.5

3.1

22.86

28.39

mg/l

0.23

272

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

3193

32009

0.99

0.11

5.6

5.7

6.00

6.07

mmol/l

2.55

2916

29006

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

157

0.89

0.11

1.4

1.5

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

450

4563

0.98

0.11

4.7

5.3

31.64

32.93

1.51

304

2914

(3043238) Trisomy 21 risk [Likelihood] in Fetus

135

0.89

0.09

1.6

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.15

0.09

1.1

1.2

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

549

5433

1.01

0.09

1.3

16.36

13.78

u/ml

0.27

184

1946

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

1.05

0.08

1.2

1.4

11.08

168090.08

nmol/l

—

(3006270) Folate [Moles/volume] in Blood

302

1.06

0.08

1.1

1.2

334.85

344.18

nmol/l

0.08

247

(3020650) Glucose [Presence] in Urine

123

0.89

0.08

1.2

1.8

0.00

0.05

estimate

0.80

123

(4133840) Spirometry

0.84

0.07

1.3

1.1

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

0.83

0.07

2.7

2.1

—

(3000475) Leukocytes [#/volume] in Synovial fluid

103

1005

1.03

0.07

1.8

1.6

16551.51

13288.13

e6/l

0.25

696

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1547

15409

1.01

0.06

5.4

6.0

2.90

3.50

ug/l

0.77

1384

13893

(3047352) Trisomy 18 risk [Likelihood] in Fetus

132

0.91

0.06

1.4

1.5

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

103

0.87

0.06

1.2

1.1

—

(3025577) Chromium [Mass/volume] in Blood

254

0.94

0.06

2.4

2.2

2.01

1.96

ug/l

0.04

212

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

517

0.97

0.06

1.4

1.3

0.69

4.11

nmol/l

0.49

493

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

332

3350

0.99

0.05

1.5

1.4

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

485

0.97

0.05

1.2

1.3

280.84

291.63

pmol/l

0.10

410

(3011288) Drugs identified in Urine by Screen method Nominal

404

0.97

0.05

1.6

2.5

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

171

0.94

0.05

1.5

73.10

56.93

ug/l

0.26

147

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

120

0.92

0.05

1.2

1.3

—

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

2632

26277

1.00

0.04

50.3

24.5

331.00

331.94

g/l

5.76

2620

26118

(3005033) Fetal Nuchal fold Thickness US

130

0.92

0.04

1.3

1.5

1.21

1.32

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

211

0.95

0.04

2.6

2.3

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

221

0.95

0.04

1.6

1.5

134.62

201.76

pmol/l

0.84

221

(3020491) Glucose [Moles/volume] in Blood

249

1.04

0.04

1.3

2.0

7.86

6.76

mmol/l

0.76

168

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

102

1.08

0.03

2.2

2.0

1.37

1.20

ug/l

0.10

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

158

0.95

0.02

1.6

1.8

2.29

11.47

nmol/l

1.62

136

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

447

0.98

0.01

1.3

0.18

0.19

nmol/l

0.55

371

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

817

0.99

0.01

1.9

9.05

11.96

iu/l

0.14

300

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

154

1.04

0.00

1.6

1.5

—

(3023511) Choriogonadotropin [Units/volume] in Urine

149

1.01

0.00

1.0

1.3

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

711

1.00

0.00

1.4

1.9

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

444

0.99

0.00

1.3

—

nmol/l

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

910

9104

1.00

0.00

3.1

3.5

0.79

0.80

ug/l

0.15

644

6358

(3020911) Cortisol [Moles/time] in 24 hour Urine

107

1.03

0.00

1.5

106.09

563.70

nmol/24h

0.94

107

(3006653) Thiamine [Moles/volume] in Blood

197

1.02

0.00

1.3

1.2

107.10

138.44

nmol/l

4.84

197

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

109

1090

1.00

-0.00

1.6

1.4

—

(3006567) Chloride [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.1

—

63.14

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

0.00

-0.00

0.0

1.5

—

1.40

—

(37021550) Renin [Units/volume] in Plasma --upright

0.93

-0.00

1.3

68.07

63.43

mu/l

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

-0.00

0.0

2.0

—

(42528595) U1 small nuclear ribonucleoprotein 70kD Ab [Presence] in Serum by Line blot

0.00

-0.00

0.0

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.00

-0.00

2.4

2.2

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3009677) Dengue virus Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3007463) Buprenorphine [Presence] in Urine

0.00

-0.00

0.0

2.6

—

(36303858) Crystals [Presence] in Urine

0.00

-0.00

0.0

1.0

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

-0.00

0.0

1.2

—

1700.00

—

(3000285) Sodium [Moles/volume] in Blood

0.99

-0.00

1.1

1.2

136.33

139.00

mmol/l

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

0.00

-0.00

0.0

1.0

—

(3033882) Carnitine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

2.0

—

36.50

—

(3013336) Amino acids [Identifier] in Serum or Plasma

0.00

-0.00

0.0

5.0

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

0.01

—

(3000722) Carnitine free (C0) [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

2.0

—

30.62

—

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: C3_NONFOLLICULAR_LYMPHOMA – Non-follicular lymphoma

GWS hits: 7

This endpoint is excluded (different definition than used in FinnGen).

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Non-follicular lymphoma

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Non-follicular lymphoma (C3_NONFOLLICULAR_LYMPHOMA)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints